A0_Samples	A18_Sex	A1_OS	A22_histological_type	A23_Tumor_tissue_site	A2_Event	A3_T	A4_N	A5_M	A6_Stage	A8_New_Event	A8_New_Event_Time	A8_New_Event_Tissue	A8_New_Event_Type	A9_Cancer_Status	additional_studies	additional_studies.additional_study.disease_code	additional_studies.additional_study.project_code	age_at_initial_pathologic_diagnosis	anatomic_neoplasm_subdivisions.anatomic_neoplasm_subdivision	axillary_lymph_node_stage_method_type	axillary_lymph_node_stage_other_method_descriptive_text	bcr_patient_barcode	bcr_patient_uuid	breast_cancer_surgery_margin_status	breast_carcinoma_estrogen_receptor_status	breast_carcinoma_immunohistochemistry_er_pos_finding_scale	breast_carcinoma_immunohistochemistry_pos_cell_score	breast_carcinoma_immunohistochemistry_progesterone_receptor_pos_finding_scale	breast_carcinoma_primary_surgical_procedure_name	breast_carcinoma_progesterone_receptor_status	breast_carcinoma_surgical_procedure_name	breast_neoplasm_other_surgical_procedure_descriptive_text	cytokeratin_immunohistochemistry_staining_method_micrometastasis_indicator	day_of_form_completion	days_to_birth	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_last_known_alive	distant_metastasis_present_ind2	drugs.drug.bcr_drug_barcode	drugs.drug.bcr_drug_uuid	drugs.drug.clinical_trail_drug_classification	drugs.drug.day_of_form_completion	drugs.drug.days_to_drug_therapy_end	drugs.drug.days_to_drug_therapy_start	drugs.drug.drug_name	drugs.drug.measure_of_response	drugs.drug.month_of_form_completion	drugs.drug.number_cycles	drugs.drug.prescribed_dose	drugs.drug.prescribed_dose_units	drugs.drug.regimen_indication	drugs.drug.regimen_indication_notes	drugs.drug.regimen_number	drugs.drug.route_of_administrations.route_of_administration	drugs.drug.therapy_ongoing	drugs.drug.therapy_types.therapy_type	drugs.drug.therapy_types.therapy_type_notes	drugs.drug.total_dose	drugs.drug.total_dose_units	drugs.drug.tx_on_clinical_trial	drugs.drug.year_of_form_completion	er_detection_method_text	er_level_cell_percentage_category	ethnicity	first_nonlymph_node_metastasis_anatomic_sites.metastatic_site_at_diagnosis	first_nonlymph_node_metastasis_anatomic_sites.metastatic_site_at_diagnosis_other	fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range	follow_ups.follow_up.additional_pharmaceutical_therapy	follow_ups.follow_up.additional_radiation_therapy	follow_ups.follow_up.additional_surgery_locoregional_procedure	follow_ups.follow_up.additional_surgery_metastatic_procedure	follow_ups.follow_up.bcr_followup_barcode	follow_ups.follow_up.bcr_followup_uuid	follow_ups.follow_up.breast_carcinoma_estrogen_receptor_status	follow_ups.follow_up.breast_carcinoma_immunohistochemistry_pos_cell_score	follow_ups.follow_up.breast_carcinoma_progesterone_receptor_status	follow_ups.follow_up.day_of_form_completion	follow_ups.follow_up.days_to_additional_surgery_locoregional_procedure	follow_ups.follow_up.days_to_additional_surgery_metastatic_procedure	follow_ups.follow_up.days_to_death	follow_ups.follow_up.days_to_last_followup	follow_ups.follow_up.days_to_last_known_alive	follow_ups.follow_up.days_to_new_tumor_event_after_initial_treatment	follow_ups.follow_up.er_detection_method_text	follow_ups.follow_up.er_level_cell_percentage_category	follow_ups.follow_up.fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range	follow_ups.follow_up.followup_case_report_form_submission_reason	follow_ups.follow_up.her2_and_centromere_17_positive_finding_other_measurement_scale_text	follow_ups.follow_up.her2_erbb_method_calculation_method_text	follow_ups.follow_up.her2_erbb_pos_finding_cell_percent_category	follow_ups.follow_up.her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	follow_ups.follow_up.her2_immunohistochemistry_level_result	follow_ups.follow_up.her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count	follow_ups.follow_up.her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count	follow_ups.follow_up.her2_neu_breast_carcinoma_copy_analysis_input_total_number	follow_ups.follow_up.her2_neu_chromosone_17_signal_ratio_value	follow_ups.follow_up.her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number	follow_ups.follow_up.immunohistochemistry_positive_cell_score	follow_ups.follow_up.lab_proc_her2_neu_immunohistochemistry_receptor_status	follow_ups.follow_up.lab_procedure_her2_neu_in_situ_hybrid_outcome_type	follow_ups.follow_up.lost_follow_up	follow_ups.follow_up.metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result	follow_ups.follow_up.metastatic_breast_carcinoma_estrogen_receptor_detection_method_text	follow_ups.follow_up.metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category	follow_ups.follow_up.metastatic_breast_carcinoma_estrogen_receptor_status	follow_ups.follow_up.metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range	follow_ups.follow_up.metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text	follow_ups.follow_up.metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category	follow_ups.follow_up.metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	follow_ups.follow_up.metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value	follow_ups.follow_up.metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score	follow_ups.follow_up.metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type	follow_ups.follow_up.metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score	follow_ups.follow_up.metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type	follow_ups.follow_up.metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status	follow_ups.follow_up.metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type	follow_ups.follow_up.metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text	follow_ups.follow_up.metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text	follow_ups.follow_up.metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text	follow_ups.follow_up.metastatic_breast_carcinoma_progesterone_receptor_detection_method_text	follow_ups.follow_up.metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category	follow_ups.follow_up.metastatic_breast_carcinoma_progesterone_receptor_status	follow_ups.follow_up.month_of_form_completion	follow_ups.follow_up.new_neoplasm_event_occurrence_anatomic_site	follow_ups.follow_up.new_neoplasm_event_type	follow_ups.follow_up.new_neoplasm_occurrence_anatomic_site_text	follow_ups.follow_up.new_tumor_event_after_initial_treatment	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_radiation_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	follow_ups.follow_up.new_tumor_events.new_tumor_event.her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count	follow_ups.follow_up.new_tumor_events.new_tumor_event.her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_detection_method_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_status	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_detection_method_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_status	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_occurrence_anatomic_site	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_occurrence_anatomic_site_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text	follow_ups.follow_up.new_tumor_events.new_tumor_event_after_initial_treatment	follow_ups.follow_up.person_neoplasm_cancer_status	follow_ups.follow_up.pgr_detection_method_text	follow_ups.follow_up.pos_finding_her2_erbb2_other_measurement_scale_text	follow_ups.follow_up.pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text	follow_ups.follow_up.pos_finding_progesterone_receptor_other_measurement_scale_text	follow_ups.follow_up.positive_finding_estrogen_receptor_other_measurement_scale_text	follow_ups.follow_up.postoperative_rx_tx	follow_ups.follow_up.progesterone_receptor_level_cell_percent_category	follow_ups.follow_up.radiation_therapy	follow_ups.follow_up.vital_status	follow_ups.follow_up.year_of_form_completion	gender	her2_and_centromere_17_positive_finding_other_measurement_scale_text	her2_erbb_method_calculation_method_text	her2_erbb_pos_finding_cell_percent_category	her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	her2_immunohistochemistry_level_result	her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count	her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count	her2_neu_breast_carcinoma_copy_analysis_input_total_number	her2_neu_chromosone_17_signal_ratio_value	her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number	histological_type	histological_type_other	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	immunohistochemistry_positive_cell_score	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	lab_proc_her2_neu_immunohistochemistry_receptor_status	lab_procedure_her2_neu_in_situ_hybrid_outcome_type	lymph_node_examined_count	margin_status	menopause_status	metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result	metastatic_breast_carcinoma_estrogen_receptor_detection_method_text	metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category	metastatic_breast_carcinoma_estrogen_receptor_status	metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range	metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text	metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category	metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value	metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score	metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score	metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status	metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type	metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text	metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text	metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text	metastatic_breast_carcinoma_progesterone_receptor_detection_method_text	metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category	metastatic_breast_carcinoma_progesterone_receptor_status	month_of_form_completion	new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	new_tumor_events.new_tumor_event.additional_radiation_therapy	new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	new_tumor_events.new_tumor_event.her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count	new_tumor_events.new_tumor_event.her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_detection_method_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_status	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_detection_method_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_status	new_tumor_events.new_tumor_event.new_neoplasm_event_occurrence_anatomic_site	new_tumor_events.new_tumor_event.new_neoplasm_event_type	new_tumor_events.new_tumor_event.new_neoplasm_occurrence_anatomic_site_text	new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text	new_tumor_events.new_tumor_event_after_initial_treatment	number_of_lymphnodes_positive_by_he	number_of_lymphnodes_positive_by_ihc	other_dx	patient_id	person_neoplasm_cancer_status	pgr_detection_method_text	pos_finding_her2_erbb2_other_measurement_scale_text	pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text	pos_finding_progesterone_receptor_other_measurement_scale_text	positive_finding_estrogen_receptor_other_measurement_scale_text	postoperative_rx_tx	primary_lymph_node_presentation_assessment	progesterone_receptor_level_cell_percent_category	race_list.race	radiation_therapy	radiations.radiation.anatomic_treatment_site	radiations.radiation.bcr_radiation_barcode	radiations.radiation.bcr_radiation_uuid	radiations.radiation.course_number	radiations.radiation.day_of_form_completion	radiations.radiation.days_to_radiation_therapy_end	radiations.radiation.days_to_radiation_therapy_start	radiations.radiation.measure_of_response	radiations.radiation.month_of_form_completion	radiations.radiation.numfractions	radiations.radiation.radiation_dosage	radiations.radiation.radiation_treatment_ongoing	radiations.radiation.radiation_type	radiations.radiation.radiation_type_notes	radiations.radiation.regimen_indication	radiations.radiation.regimen_indication_notes	radiations.radiation.units	radiations.radiation.year_of_form_completion	stage_event.ann_arbor.b_symptoms	stage_event.ann_arbor.extranodal_involvement	stage_event.clinical_stage	stage_event.gleason_grading.gleason_score	stage_event.gleason_grading.primary_pattern	stage_event.gleason_grading.secondary_pattern	stage_event.gleason_grading.tertiary_pattern	stage_event.igcccg_stage	stage_event.masaoka_stage	stage_event.pathologic_stage	stage_event.psa.days_to_psa	stage_event.psa.psa_value	stage_event.serum_markers	stage_event.system_version	stage_event.tnm_categories.clinical_categories.clinical_M	stage_event.tnm_categories.clinical_categories.clinical_N	stage_event.tnm_categories.clinical_categories.clinical_T	stage_event.tnm_categories.pathologic_categories.pathologic_M	stage_event.tnm_categories.pathologic_categories.pathologic_N	stage_event.tnm_categories.pathologic_categories.pathologic_T	surgical_procedure_purpose_other_text	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_tissue_site	tumor_tissue_site_other	vital_status	year_of_form_completion	year_of_initial_pathologic_diagnosis	Tumor_Sample_Barcode	Cluster
TCGA-A1-A0SK	FEMALE	967	Other, specify	Breast	Dead	T2	N0 (i-)	M0	Stage IIA	1	NA			Not Available	NA			54	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A1-A0SK	a5b44d66-c162-46b5-9df2-86305f0385c5	Negative	Negative	Not Available	Not Available	Not Available	Other	Negative	Lumpectomy	surgical resection	Not Available	6	-20048	967	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A1-A0SK-F15926	5F98C53B-5EE8-444C-9089-1E7EF433117D				7		Not Available	967	Not Available		Not Available				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available																																		WITH TUMOR			Not Available			Not Available		Not Available	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Neuroendocrine carcinoma, large-cell type, high-grade	No	C50.9	8013/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Negative	Not Evaluated	4	Positive	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	Not Available	No	A0SK	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A1	Breast	Not Applicable	Dead	2010	2007	TCGA-A1-A0SK-01A-12D-A099-09	C1
TCGA-A1-A0SP	FEMALE	584	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	584			TUMOR FREE	NA			40	Right	Axillary lymph node dissection alone	Not Available	TCGA-A1-A0SP	a9bb8159-32f0-454c-a946-b3286a52b9d5	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Not Available	6	-14954	Not Applicable	0	584	Not Available	Not Available	TCGA-A1-A0SP-D4489	D44AD8B4-4B21-4F10-A99A-EEB2C92222FD	Not Available	7	173	108	Not Available	Not Available	12	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	Not Available	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	3	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	Not Available	Yes	A0SP	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A1-A0SP-R4223	5E22E8A7-7CD2-4DED-A532-43CB2DEF4F91	Not Available	7	259	215	Not Available	12	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2010	2007	TCGA-A1-A0SP-01A-11D-A099-09	C2
TCGA-A2-A04U	FEMALE	2654	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	2654			TUMOR FREE	NA			47	Right	Sentinel node biopsy alone	Not Available	TCGA-A2-A04U	1c3610f7-e0aa-48d7-9a27-0dbaf6e244f9	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	5	-17474	Not Applicable	0	671	Not Available	Not Available	TCGA-A2-A04U-D6673;TCGA-A2-A04U-D6680;TCGA-A2-A04U-D6675;TCGA-A2-A04U-D6679	7c4f7833-834c-4045-b558-4a53c47aec04;14adba24-28a7-4eac-bcdf-6542a26395b8;15e8f3ac-8410-402b-85c4-76caeb242226;0a1f5288-fb98-4a32-ab56-4dca69f8d629	Not Available;Not Available;Not Available;Not Available	7;7;7;7	120;671;120;197	78;481;78;134	Adriamycin;Zometa;Cytoxan;Taxotere	Not Available;Not Available;Not Available;Not Available	1;1;1;1	4;3;4;4	116;4;1160;140-192	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;4;2;3	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy	Not Available;Bisphosphonate;Not Available;Not Available	464;12;4640;612	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A2-A04U-F9334;TCGA-A2-A04U-F59317	99826B0C-9A4E-43B0-9EF8-F52CF27DD53E;022819FE-3C6C-4DDD-90FD-EBF7BD427042	Not Available;None	Not Available;None	Not Available;None	17;8	Not Available;None	Not Available;None	Not Applicable;Not Applicable	1486;2654	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;5					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Unknown	TUMOR FREE;Unknown	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	2.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Positive	3	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	1	No	A04U	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2004	TCGA-A2-A04U-01A-11D-A10Y-09	C1
TCGA-A2-A0CM	FEMALE	754	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0 (i-)	M0	Stage IIA	0	754			WITH TUMOR	NA			40	Left	Sentinel node biopsy alone	Not Available	TCGA-A2-A0CM	eb2dbb4f-66b6-4525-8323-431970f7a64e	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	6	-14969	754	0	Not Available	Not Available	Not Available	TCGA-A2-A0CM-D2018;TCGA-A2-A0CM-D2026;TCGA-A2-A0CM-D2020;TCGA-A2-A0CM-D2022;TCGA-A2-A0CM-D2024;TCGA-A2-A0CM-D2027	51cca21e-fd29-4d59-9de1-916fc77056e0;80df2add-560a-429f-9f42-6469a5e88bba;88adeb77-bcc1-48cb-a270-92cdc1fe8f24;afae9c46-2307-4844-b80b-cb436fc1e8bb;2a0f9e7d-47a8-4977-9845-f9255d292e92;e8027663-89df-4c62-9c8c-b7709606de60	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	23;23;24;24;24;24	147;615;147;Not Available;601;433	98;391;98;234;391;391	Adriamycin;Capecetabine;Cytoxan;Tamoxifen;Docetaxel;Zometa	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8	4;8;4;Not Available;8;2	106;2000-3500;1062;20;100-131;4	mg;mg;mg;mg/day;mg;mg	ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;5;2;3;4;6	IV;PO;IV;PO;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Other, specify in notes	Not Available;Not Available;Not Available;Not Available;Not Available;Bisphosphonate therapy	424;24400;4248;Not Available;890;8	mg;mg;mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	NO	NO	Not Available	TCGA-A2-A0CM-F2013	5609C4A1-D006-4EAF-B197-174CAF31D43E	Not Available	Not Available	Not Available	6	Not Available	Not Available	754	Not Available	Not Available	382	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	9																																						WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2010	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Excisional Biopsy	Negative	Not Evaluated	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	0	No	A0CM	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Dead	2010	2003	TCGA-A2-A0CM-01A-31W-A050-09	C2
TCGA-A2-A0D0	FEMALE	2048	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	2048			TUMOR FREE	NA			60	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0D0	324bcba2-f6a4-45a6-807c-215bdffcca21	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	16	-22115	Not Applicable	0	643	Not Available	Not Available	TCGA-A2-A0D0-D1851;TCGA-A2-A0D0-D1852	f423013c-d03a-46bf-9df8-4261396bdc99;e74bfde2-3653-4de9-bff3-80e8d53d150d	Not Available;Not Available	16;16	125;125	62;62	Cytoxan;Docetaxel	Not Available;Not Available	9;9	4;4	1230;153	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;2	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	4920;612	mg;mg	Not Available;Not Available	2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A0D0-F13729;TCGA-A2-A0D0-F59399	4F4DEDB3-173C-4B24-B46B-D1DDCB67A318;D16C3023-B057-4408-8F50-C78DEA6876E1				9;12		Not Available;None	Not Applicable;Not Applicable	643;2048		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Unknown	TUMOR FREE;Unknown			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	1.17	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Negative	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0D0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2008	TCGA-A2-A0D0-01A-11W-A019-09	C1
TCGA-A2-A0D2	FEMALE	1027	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	1027			TUMOR FREE	NA			45	Left Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0D2	99e32c59-aa73-43fa-88c9-399ddadb2c72	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	16	-16623	Not Applicable	0	761	Not Available	Not Available	TCGA-A2-A0D2-D1822;TCGA-A2-A0D2-D1823;TCGA-A2-A0D2-D1824	0b7ae681-1762-4598-b9c5-79d77a5f208a;956680fa-6dc8-437e-8529-32d884b2e572;ef46d977-60f0-4915-9438-4c3e9c7e66d8	Not Available;Not Available;Not Available	17;17;17	123;123;179	74;74;137	Adriamycin;Cytoxan;Taxol	Not Available;Not Available;Not Available	9;9;9	4;4;4	108-109;1086;325-329	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;3	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	435;4344;1308	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0D2-F14458	76B9C470-A143-4376-92CB-58317C2C3764				9		Not Available	Not Applicable	1027		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	1.05	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Negative	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	4	No	A0D2	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Regional site;Regional site	TCGA-A2-A0D2-R1825;TCGA-A2-A0D2-R70743	a912f4e0-99c5-408c-b321-73e7f5d077e0;12036BDE-8D83-40CA-AA13-7AFEFCF03DD5	1;Not Available	17;3	270;270	230;230	Not Available;Complete Response	9;3	28;28	5040;5040	NO;NO	EXTERNAL BEAM;External	Not Applicable;Not Applicable	ADJUVANT;Not Available	Not Available;Not Available	cGy;cGy	2010;2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2008	TCGA-A2-A0D2-01A-21W-A050-09	C2
TCGA-A2-A0SX	FEMALE	1534	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	1	1239			WITH TUMOR	NA			48	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0SX	18d35983-ea6a-4b70-a209-9bef37595956	Negative	Negative	Not Available	Not Available	Not Available	Lumpectomy	Negative	Lumpectomy	Not Applicable	YES	9	-17774	Not Applicable	0	1288	Not Available	Not Available	TCGA-A2-A0SX-D4024;TCGA-A2-A0SX-D4019;TCGA-A2-A0SX-D4023;TCGA-A2-A0SX-D4025;TCGA-A2-A0SX-D14036	8f6e3477-88fd-4f1b-b06f-0e3510b0ac5d;76901188-6afa-4900-ae30-7d296985c5de;a0280f47-3ba8-42cf-ab14-ff4fd7db88b0;16e4fd14-6c2b-4c7e-964a-c240c2b36ceb;634383B8-9F0E-4A8B-84FE-B308540A6F38	Not Available;Not Available;Not Available;Not Available;Not Available	12;20;24;24;11	132;132;1359;1359;Not Available	62;62;1289;1289;1429	Adriamycin;Cytoxan;Carboplatin;Gemcitabine;Xeloda	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;5	6;6;4;4;Not Available	100;1000;610;1800;1500-2000	mg;mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;1;3;4;5	IV;IV;IV;IV;PO	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	600;6000;2203;7200;Not Available	mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES;Not Available	NO;Not Available	YES;Not Available	Not Available;None	TCGA-A2-A0SX-F4018;TCGA-A2-A0SX-F14037	2FBA2DC6-991D-4F21-A885-0C9489F2546E;FD49FD62-003E-47C4-82ED-06FDB0E1CF23	Negative;None	Not Available;None	Negative;None	9;14	1239;None	Not Available;Not Available	Not Applicable;Not Applicable	1288;1534	Not Available;None	1239;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	0;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Negative;None	Not Evaluated;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	11;7	None;Not Available	None;Not Available	None;Not Available	None;NO																																		WITH TUMOR;WITH TUMOR	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	0	No	A0SX	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0SX-R4026	b73451cc-daa2-4f73-bf06-517ddecd777f	1	12	213	Not Available	Not Available	11	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2007	TCGA-A2-A0SX-01A-12D-A099-09	C2
TCGA-A2-A0T0	FEMALE	533	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	533			TUMOR FREE	NA			59	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0T0	95c53f69-0f05-4348-822a-571f3d757001	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	12	-21575	Not Applicable	0	337	Not Available	Not Available	TCGA-A2-A0T0-D3430;TCGA-A2-A0T0-D3434;TCGA-A2-A0T0-D3432	7b30d8b7-1a91-4f14-93d1-1d690c083a3a;d86d4e6c-4305-493c-b8bf-968971f358c9;e011bb8b-77b8-4daa-9bea-75f9c039e676	Not Available;Not Available;Not Available	12;12;12	234;234;234	50;50;50	Taxotere;Cytoxan;Adriamycin	Not Available;Not Available;Not Available	11;11;11	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;3;2	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0T0-F13944	B0DC7631-8558-431C-B56D-B8C9C74C29F5				18		Not Available	Not Applicable	533		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	2	Not Available	No	A0T0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0T0-R3435	216a63e4-215a-4fc7-a5ea-e50076307b40	1	12	323	262	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009	TCGA-A2-A0T0-01A-22D-A099-09	C1
TCGA-A2-A0T2	FEMALE	255	Infiltrating Ductal Carcinoma	Breast	Dead	T3	N3	M1	Stage IV	0	255			WITH TUMOR	NA			66	Right	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0T2	128d198e-9b22-427c-90db-3714455f3a17	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	12	-24235	255	0	Not Available	Not Available	Not Available	TCGA-A2-A0T2-D3707	374f0db8-26b8-4cd4-828d-1250a5a81df3	Not Available	12	225	105	Xeloda	Not Available	11	4	3	g/day	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	Not Available	g/day	Not Available	2010	Not Available	<10%	NOT HISPANIC OR LATINO	Liver	Abdomen	Not Available	NO	NO	Not Available	NO	TCGA-A2-A0T2-F3706	A366E180-A36C-447C-BDDE-931193A02AA4	Not Available	Not Available	Not Available	12	Not Available	Not Available	255	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11																																						WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	NO	Dead	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	No	A0T2	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Regional site	TCGA-A2-A0T2-R3708	86535c68-8c55-421f-ad89-586c8d68c5ed	1	12	199	179	Not Available	11	12	3000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M1	N3	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Dead	2010	2009	TCGA-A2-A0T2-01A-11W-A097-09	C1
TCGA-A2-A0YE	FEMALE	554	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	554			TUMOR FREE	NA			48	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A0YE	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	10	-17727	Not Applicable	0	253	Not Available	Not Available	TCGA-A2-A0YE-D5668;TCGA-A2-A0YE-D5669;TCGA-A2-A0YE-D5670	8aff8385-be06-4dc8-900a-bd3755cdd8e5;635760ed-24dd-4491-bd61-c6793eb02a35;a2d7f767-e939-4557-b767-387f1623d5ba	Not Available;Not Available;Not Available	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Taxotere;Adriamycin;Cytoxan	Not Available;Not Available;Not Available	12;12;12	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;3	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0YE-F15771	7D263191-4081-4DD8-9E46-6D37D7714745				30		Not Available	Not Applicable	554		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	No membrane staining or incomplete membrane staining in <10% of tumor cells is negative	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	1	Not Available	No	A0YE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0YE-R5671	2fe7a331-456c-44f1-913e-6bb5abdea657	1	8	267	225	Not Available	12	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2010	TCGA-A2-A0YE-01A-11D-A10G-09	C2
TCGA-A2-A1G6	FEMALE	501	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	501			TUMOR FREE	NA			50	Right	Axillary lymph node dissection alone	Not Available	TCGA-A2-A1G6	295cf595-4a29-46a3-a0c5-e5f08f947031	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	22	-18514	Not Applicable	0	132	Not Available	NO	TCGA-A2-A1G6-D12537;TCGA-A2-A1G6-D12532;TCGA-A2-A1G6-D12535	03170c14-0cc8-47b8-8211-e7feae86ed65;b86d0b45-cd36-46d7-9964-b170549420ac;57fef464-1259-484f-8b66-7473fa062401	Not Available;Not Available;Not Available	28;28;28	172;119;119	132;69;69	Docetaxel;Adriamycin;Cytoxan	Not Available;Not Available;Not Available	4;4;4	3;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	3;1;2	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A1G6-F20947	3427FD70-83B5-4A78-A617-838013915E15				9		Not Available	Not Applicable	501		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	4	Not Available	No	A1G6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site;Regional site;Regional site	TCGA-A2-A1G6-R20946;TCGA-A2-A1G6-R31779;TCGA-A2-A1G6-R31780	AF32408D-BB2D-4910-8E8A-B62DC6DDE68E;8A5DBB7F-2FCD-45AF-807E-57F4DE9EA749;0C5AA321-F0DC-4B91-9633-0CABB1EDE7C7	1;2;3	25;9;9	283;283;293	249;249;284	Not Available;Not Available;Not Available	1;5;5	25;25;8	4500;4500;1600	NO;NO;NO	EXTERNAL BEAM;EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable;Not Applicable	ADJUVANT;ADJUVANT;ADJUVANT	Not Available;Not Available;Not Available	cGy;cGy;cGy	2012;2012;2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2011	2010	TCGA-A2-A1G6-01A-11D-A13L-09	C2
TCGA-A2-A3XT	FEMALE	2770	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	2770			TUMOR FREE	NA			45	Left	Other (specify)	FNA plus axillary lymph node dissection	TCGA-A2-A3XT	C72CB184-462D-4009-9CDB-848782FF8A76	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	17	-16649	Not Applicable	0	2238	Not Available	Not Available	TCGA-A2-A3XT-D34495;TCGA-A2-A3XT-D34496;TCGA-A2-A3XT-D34497	C93B9D6C-DE38-4B66-AA69-C788731E6DA2;314F8E23-81C1-41B5-BB1D-78A78525EE50;3E9B81CF-BFAD-4C78-AC24-32461C485692	Not Available;Not Available;Not Available	17;17;17	83;83;161	35;35;97	Cyclophosphamide;Doxorubicin;Docetaxel	Partial Response;Partial Response;Partial Response	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A3XT-F43309;TCGA-A2-A3XT-F55841	32EAD95B-751B-4BFD-BE2E-908EA3CE2617;60EA646B-4B74-49E4-8493-AE2DA1AF4BFA				16;16			Not Applicable;Not Applicable	2525;2770																				NO;NO																						5;1					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.13	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Negative	Negative	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A3XT	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field;Regional site;Regional site;Primary Tumor Field	TCGA-A2-A3XT-R34498;TCGA-A2-A3XT-R34499;TCGA-A2-A3XT-R34500;TCGA-A2-A3XT-R34501	3FC8B1C4-9668-4CC8-B355-AF3B27746C49;8749065D-442D-4F58-98EA-5CFEAC7F5AB3;44C63D6A-9809-45D0-A622-FC1FFD502681;D6509E2C-F849-48E2-9026-A7B97686D7D7	Not Available;Not Available;Not Available;Not Available	17;17;17;17	275;275;275;282	233;233;233;278	Complete Response;Complete Response;Complete Response;Complete Response	8;8;8;8	28;28;28;5	5040;5040;868;1000	NO;NO;NO;NO	External;External;External;External	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	cGy;cGy;cGy;cGy	2012;2012;2012;2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2012	2006	TCGA-A2-A3XT-01A-11D-A22X-09	C2
TCGA-A2-A3XX	FEMALE	1439	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0	M0	Stage IIA	0	1439			TUMOR FREE	NA			49	Left Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A3XX	53886143-C1C6-40E9-88E6-E4E5E0271FC8	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	15	-17981	Not Applicable	0	1168	Not Available	NO	TCGA-A2-A3XX-D34438;TCGA-A2-A3XX-D34439;TCGA-A2-A3XX-D34441	9F081506-F377-47BB-8EE6-EDE38541E7B9;588DB182-2F95-48D2-A365-0BDF34B3C1FB;B6FD1396-6FE8-44FF-A6AC-72B380261AD5	Not Available;Not Available;Not Available	15;15;15	129;129;185	80;80;143	Cyclophosphamide;Adriamycin;Paclitaxel	Complete Response;Complete Response;Complete Response	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A3XX-F43310	F765B888-581A-4FC9-804A-2FD66F290AF9				16			1439	Not Available																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.25	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A3XX	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2012	2009	TCGA-A2-A3XX-01A-21D-A23C-09	C2
TCGA-A7-A0DA	FEMALE	1085	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1085			TUMOR FREE	NA			62	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A0DA	3afa1e93-1df8-4e4c-aaa4-557463f4bb77	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Not Available	10	-22708	Not Applicable	0	373	Not Available	Not Available	TCGA-A7-A0DA-D6123;TCGA-A7-A0DA-D6125;TCGA-A7-A0DA-D6126	848337bd-29ff-4b6c-8710-4bb3ac828398;84e6d642-6da6-4216-a376-2077ac969442;1b1e115e-9a35-4b44-a883-94573341a893	Not Available;Not Available;Not Available	13;13;13	107;107;199	65;65;122	Adriamycin;Cytoxan;Taxol	Not Available;Not Available;Not Available	1;1;1	4;4;12	100;990-1000;90-130	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	400;3990;1435	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A7-A0DA-F6131;TCGA-A7-A0DA-F38487	528F3E9A-532F-464C-944C-2B0B7952D753;492F04DA-FBF7-48D8-99A9-9F4490E79F21	Not Available;None	Not Available;None	Not Available;None	13;14	Not Available;None	Not Available;None	Not Applicable;Not Applicable	373;1085	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;12					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2011;2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	Not Available	No	A0DA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A0DA-R5953	43ddf4b7-e2e9-4629-9fbc-01598b2cb8aa	1	10	274	226	Not Available	1	33	6100	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2011	2009	TCGA-A7-A0DA-01A-31D-A10Y-09	C1
TCGA-A7-A26G	FEMALE	722	Other, specify	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	722			Not Available	NA			50	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A26G	5ed024e8-d05e-4c65-9441-eda9930ccc82	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	NO	10	-18362	Not Applicable	0	210	Not Available	NO	TCGA-A7-A26G-D14906;TCGA-A7-A26G-D14908	90ABBBFF-599A-4245-A3A3-FAFC37EEC924;7D7AE68F-EC3A-4BA6-A19A-4A4D2590CA7E	Not Available;Not Available	10;10	152;152	89;89	Taxotere;Cytoxan	Not Available;Not Available	8;8	4;4	160-168;1308-1344	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	648;5292	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A7-A26G-F29419;TCGA-A7-A26G-F39047	91E3B3A1-3446-4119-8A7F-2419BAEC4831;1C41020E-8C83-4C5D-8CB2-6926012E4ED9				16;9		Not Available;None	Not Applicable;Not Applicable	334;722		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;1	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Invasive ductal carcinoma with Metaplastic features (Area of sarcomatoid carcinoma)	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A26G	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Total Mastectomy	YES	NO	A7	Breast	Not Applicable	Alive	2011	2010	TCGA-A7-A26G-01A-21D-A167-09	C2
TCGA-A7-A4SE	FEMALE	644	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	644			TUMOR FREE	NA			54	Left	Sentinel node biopsy alone	Not Available	TCGA-A7-A4SE	DBF6F981-15CC-40AD-91AC-A66360405FBD	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	22	-20080	Not Applicable	0	371	Not Available	Not Available	TCGA-A7-A4SE-D41891;TCGA-A7-A4SE-D41892;TCGA-A7-A4SE-D41893	8C1D4FAD-B3C5-4009-94B8-51BE6B474423;B8237736-7799-4490-A1CA-2A15E2985B17;5FA600E2-E487-4345-A4BE-E4A7AD3738EB	Not Available;Not Available;Not Available	2;2;2	91;91;154	49;49;105	Adriamycin;Cytoxan;Taxol	Complete Response;Complete Response;Complete Response	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A4SE-F50162	EA17641D-048D-48C9-8C6F-24D1888E0196				16			Not Applicable	644																				YES																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A4SE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2011	TCGA-A7-A4SE-01A-11D-A25Q-09	C1
TCGA-A7-A6VV	FEMALE	313	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	313			TUMOR FREE	NA			51	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A6VV	57AF5C72-0D60-4A6B-B1B4-EC6DAB90F80F	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	22	-18695	Not Applicable	0	181	Not Available	Not Available	TCGA-A7-A6VV-D57247;TCGA-A7-A6VV-D57248	8A804A22-B193-4C71-8EBB-6FD22D9F605E;52B5F633-7FB7-42E1-A8EC-60B50825FBCF	Not Available;Not Available	6;6	266;266	160;160	Cyclophosphamide;Taxotere	Complete Response;Complete Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A6VV-F57249	2A10E9C7-16B5-4CDC-8548-D21B927922EE				6			Not Applicable	313																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	5	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A6VV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2013	TCGA-A7-A6VV-01A-22D-A33E-09	C1
TCGA-A7-A6VW	FEMALE	285	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	285			TUMOR FREE	NA			48	Left	Sentinel node biopsy alone	Not Available	TCGA-A7-A6VW	98E709E7-E195-4B37-9537-F6081AFFB609	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	29	-17539	Not Applicable	0	176	Not Available	Not Available	TCGA-A7-A6VW-D57225;TCGA-A7-A6VW-D57226;TCGA-A7-A6VW-D57254	037B0D49-1CCC-47FB-9442-F8841E1663C5;DD497F99-3155-4D4E-904E-FD5904316A52;02D81B38-5418-4F7D-B18B-0AE11DBE806B	Not Available;Not Available;Not Available	6;6;6	257;134;134	148;84;84	Taxol;Doxorubicin;Cyclophosphamide	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A6VW-F57227	4E6B8FB6-BAFC-4287-BC6A-AB3BA00294C9				6			Not Applicable	285																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A6VW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-A7-A6VW-R57253	75FCD986-D2B7-4F5B-B37A-FE0AF6FC2AC8	Not Available	31	331	285	Complete Response	3	28	50.40	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2013	TCGA-A7-A6VW-01A-21D-A33E-09	C1
TCGA-A7-A6VY	FEMALE	266	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	266			TUMOR FREE	NA			48	Right;Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A6VY	E8EA576B-EB16-44F7-B241-DAEFC1375388	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	25	-17640	Not Applicable	0	125	Not Available	Not Available	TCGA-A7-A6VY-D57229;TCGA-A7-A6VY-D57230;TCGA-A7-A6VY-D57231	5D3D1784-E381-460E-B773-DE56BABA6BCF;2DB83098-CA32-424E-ACFA-3207D2899E95;5D349A3C-E310-48A5-A0E1-248ABE65246D	Not Available;Not Available;Not Available	6;6;6	111;111;167	68;68;126	Cyclophosphamide;Doxorubicin;Paclitaxel	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A6VY-F57257	11D83905-3096-497D-A947-096697D1CD40				6			Not Applicable	266																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	Not Available	No	A6VY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field;Primary Tumor Field	TCGA-A7-A6VY-R57255;TCGA-A7-A6VY-R57256	395D4E07-8431-402C-932F-61689DB69B9E;E45FC357-F0D6-4CAF-A745-480BB0BD7C42	Not Available;Not Available	6;6	247;266	211;251	Complete Response;Complete Response	3;3	25;10	4500;2000	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2013	TCGA-A7-A6VY-01A-12D-A33E-09	C1
TCGA-A8-A07O	FEMALE	304	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	304			TUMOR FREE	NA			51	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07O	cf9db1af-17f0-490e-8139-142bd704763a	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-18870	Not Applicable	0	304	Not Available	Not Available	TCGA-A8-A07O-D37865	FE74A740-3180-4A13-A733-54DDF7212A91	Not Available	6	151	61	Not Available	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07O-F40831	A8FC8B58-BD10-40C0-BEE5-E0DA7F4431C4				2			Not Applicable	304																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07O	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A07O-R38184	B6552840-8AC7-4FA4-8CE2-7EAB6774004A	Not Available	11	212	182	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009	TCGA-A8-A07O-01A-11W-A019-09	C2
TCGA-A8-A08R	FEMALE	30	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	30			TUMOR FREE	NA			52	Left	Not Available	Not Available	TCGA-A8-A08R	6412854a-f874-469e-9d1f-8bd3ae5bd41d	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-19298	Not Applicable	0	30	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08R	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008	TCGA-A8-A08R-01A-11W-A050-09	C2
TCGA-A8-A09X	FEMALE	426	Infiltrating Lobular Carcinoma	Breast	Dead	T2	N3a	M0	Stage IIIC	0	426			Not Available	NA			62	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-A8-A09X	27b05b15-a44b-45ed-a6e3-e7d1ca488ea9	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-22858	426	0	Not Available	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09X	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Dead	2011	2009	TCGA-A8-A09X-01A-11W-A019-09	C2
TCGA-AC-A2BK	FEMALE	2222	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	MX	Stage IIIA	0	2222			TUMOR FREE	NA			78	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AC-A2BK	6FA2A667-9C36-4526-8A58-1975E863A806	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	16	-28625	Not Applicable	0	1172	Not Available	NO	TCGA-AC-A2BK-D43988;TCGA-AC-A2BK-D43990;TCGA-AC-A2BK-D43991;TCGA-AC-A2BK-D43992	9DE66FB7-BCEC-4B84-B97E-1A9F68D8E87A;1502DE28-84D8-4351-BCEE-9661DACD2B21;4869DCB0-723E-46A0-AB90-3D5FF038203A;8283B14A-D235-4D20-B272-9B4A8A095886	Not Available;Not Available;Not Available;Not Available	10;10;10;10	136;136;164;164	73;73;149;149	Cytoxan;Adriamycin;Taxol;Avastin	Complete Response;Complete Response;Complete Response;Complete Response	6;6;6;6	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-AC-A2BK-F43987	256CE2CD-BE4C-49CD-8395-1A4991708D69				10			Not Applicable	2222																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	6	Not Available	No	A2BK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-AC-A2BK-R43989	5F23873B-7D5F-43C9-86F1-820C26351615	Not Available	10	254	203	Complete Response	6	25	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N2a	T2	Not Available	NO	YES	AC	Breast	Not Applicable	Alive	2011	2006	TCGA-AC-A2BK-01A-11D-A21Q-09	C1
TCGA-AC-A2QH	FEMALE	1005	Metaplastic Carcinoma	Breast	Alive	T3	N0	MX	Stage IIB	0	1005			TUMOR FREE	NA			58	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AC-A2QH	67C5F371-3FA9-47C5-8B15-C2DD9ACC8519	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	YES	18	-21488	Not Applicable	0	31	Not Available	NO	TCGA-AC-A2QH-D64102;TCGA-AC-A2QH-D64103;TCGA-AC-A2QH-D64104	35EB8EC6-E1A8-4C43-9FF1-8743A658A8F9;5555AA7B-5597-4D92-BC2B-20E6EC3BB630;CFAD5F9E-8CC3-430E-A4BC-F6079D09BC84	Not Available;Not Available;Not Available	26;26;26	208;208;208	94;94;94	Cytoxan;Adriamycin;Aloxi	Complete Response;Complete Response;Complete Response	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Ancillary	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A2QH-F64100	91E76EF9-3B27-4249-8F36-04C648DEAA31				26			Not Applicable	1005																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Metaplastic Carcinoma	Not Applicable	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A2QH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AC-A2QH-R64101	731DA497-5254-41D5-A65B-F5F0222CE5A1	Not Available	26	305	246	Complete Response	8	33	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T3	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2011	2011	TCGA-AC-A2QH-01A-11D-A18P-09	C1
TCGA-AC-A6IW	FEMALE	413	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	MX	Stage IIA	0	413			TUMOR FREE	NA			73	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AC-A6IW	8183F0FB-2303-4D7B-BCCD-55E5031FC7DF	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	15	-26896	Not Applicable	0	21	Not Available	Not Available																								Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A6IW-F64106	A62988AE-F527-4DAB-B4F0-F6FD96DC156F				26			Not Applicable	413																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A6IW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	<10%	BLACK OR AFRICAN AMERICAN	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2013	2013	TCGA-AC-A6IW-01A-12D-A33E-09	C2
TCGA-AC-A7VC	FEMALE	1	Metaplastic Carcinoma	Breast	Alive	T3	N0	MX	Stage IIB	0	1			TUMOR FREE	NA			56	Left	Sentinel node biopsy alone	Not Available	TCGA-AC-A7VC	2B36853F-34D3-47C5-BA6A-E5A93233D2B1	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	29	-20479	Not Applicable	0	1	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Metaplastic Carcinoma	Not Applicable	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A7VC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T3	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2014	2013	TCGA-AC-A7VC-01A-11D-A351-09	C1
TCGA-AN-A04D	FEMALE	52	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	52			TUMOR FREE	NA			58	Left Upper Outer Quadrant	No axillary staging	Not Available	TCGA-AN-A04D	49717f75-0f2d-4e1c-9a12-f1cd7877b80a	Not Available	Negative	Not Available	0	Not Available	Modified radical mastectomy	Negative	Simple Mastectomy	Not Applicable	NO	20	-21426	Not Applicable	0	52	Not Available	Not Available																								Allred (Biocare)	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A04D-F68975	EE0071B8-0C20-431B-8150-16603C61D46F				24			Not Applicable	52																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						Unknown		Unknown	Alive	2014	FEMALE	Not Available	Dako Hercept Test	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	2	0	No	A04D	TUMOR FREE	Allred (Biocare)	Not Available	Not Available	0	0	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2008	TCGA-AN-A04D-01A-21W-A050-09	C2
TCGA-AN-A0AL	FEMALE	227	Infiltrating Ductal Carcinoma	Breast	Alive	T4	N0	M0	Stage IIIB	0	227			TUMOR FREE	NA			41	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A0AL	3e9f93c0-aa79-4b4c-bd6c-b3325912362a	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	21	-15286	Not Applicable	0	198	Not Available	Not Available																								dextran coated charcoal	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0AL-F68944	02C99963-3C0B-4888-BD6F-F1C920E08720				23			Not Applicable	227																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	dextran coated charcoal	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0AL	TUMOR FREE	dextran coated charcoal	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T4	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010	TCGA-AN-A0AL-01A-11W-A019-09	C2
TCGA-AN-A0AR	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	10			TUMOR FREE	NA			55	Right Upper Inner Quadrant	No axillary staging	Not Available	TCGA-AN-A0AR	ebc460c2-df88-4dc0-a2c0-aca8072b75ad	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	28	-20152	Not Applicable	0	10	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0AR-F68946	07FE1A95-D842-4DF8-9EAA-36D34C7989DD				23			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0AR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010	TCGA-AN-A0AR-01A-11W-A019-09	C2
TCGA-AN-A0AT	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	10			TUMOR FREE	NA			62	Right Upper Inner Quadrant	No axillary staging	Not Available	TCGA-AN-A0AT	05506f4c-e701-4a9d-ae06-97f066aade43	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	28	-22798	Not Applicable	0	10	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0AT-F68948	6E5C0241-D8BE-4DB8-8893-0E939CCED8F6				23			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0AT	TUMOR FREE	Not Available	0	Not Available	0	0	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010	TCGA-AN-A0AT-01A-11D-A045-09	C2
TCGA-AN-A0G0	FEMALE	16	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	16			TUMOR FREE	NA			56	Right Upper Inner Quadrant	No axillary staging	Not Available	TCGA-AN-A0G0	96312510-c126-485d-8109-ed81844a1dc3	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	29	-20504	Not Applicable	0	16	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0G0-F68970	15A83D83-B3D3-45E7-8262-3E6CDC4B1C5D				24			Not Applicable	16																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0G0	TUMOR FREE	Not Available	Not Available	Not Available	0	0	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010	TCGA-AN-A0G0-01A-11W-A050-09	C1
TCGA-AN-A0XU	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	10			Not Available	NA			54	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-AN-A0XU	a1da9db1-db11-4f4d-a249-c738db81b87e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Applicable	Not Available	28	-20052	Not Applicable	0	10	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0XU-F68961	4194E7B2-A2E1-4D92-80F0-394939FBCD04				23			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A0XU	Not Available	Not Available	Not Available	Not Available	0	0	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2011	2010	TCGA-AN-A0XU-01A-11D-A10G-09	C1
TCGA-AO-A0J4	FEMALE	1587	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	1587			TUMOR FREE	NA			41	Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-AO-A0J4	a9b7d7fe-be31-4f71-afee-c1bfdf511888	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	19	-15052	Not Applicable	0	294	Not Available	Not Available	TCGA-AO-A0J4-D2749;TCGA-AO-A0J4-D2748;TCGA-AO-A0J4-D2750	60d39515-fbed-4588-80f8-0a3c0172f94e;e8d55b3d-7228-4fe0-b888-86ebfb98dc59;1a7870eb-a79b-421d-af13-fcf0d3654788	Not Available;Not Available;Not Available	19;19;19	175;175;203	131;131;189	Doxorubicin;Cyclophasphamide;Paclitaxel	Not Available;Not Available;Not Available	9;9;9	4;4;2	60;600;175	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	400;4000;580	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0J4-F2742;TCGA-AO-A0J4-F15478	D22091C4-FC26-42F1-AF72-46DADE0922AC;303D8EF0-9002-4B68-8E12-C5C5C5119275	Not Available;None	Not Available;None	Not Available;None	19;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	294;1587	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0J4	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-AO-A0J4-R2747	a5875abd-4fb2-48ad-9f4e-56c021726547	1	19	294	265	Not Available	9	21	5240	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2009	TCGA-AO-A0J4-01A-11W-A050-09	C2
TCGA-AO-A0J6	FEMALE	1140	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1140			TUMOR FREE	NA			61	Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-AO-A0J6	e9f4f373-37a5-48ad-a1a0-b0d47820111a	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	19	-22462	Not Applicable	0	775	Not Available	Not Available	TCGA-AO-A0J6-D3107;TCGA-AO-A0J6-D3105;TCGA-AO-A0J6-D3103	73049389-f0b2-42ee-8cb0-3220e24c2132;a007109f-8d09-47c0-8962-c3fdccc14bd9;56b00f1d-94c6-47aa-bfe8-3475b64b8754	Not Available;Not Available;Not Available	19;19;19	172;116;116	130;74;74	PACLITAXEL;DOXORUBICIN;CYCLOPHOSPHAMIDE	Not Available;Not Available;Not Available	9;9;9	4;4;4	175;60;600	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1320;440;4400	mg;meq;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0J6-F3099;TCGA-AO-A0J6-F15479	1CD5D03B-E10B-4BB5-B3E9-E49C8054290C;970D7D07-69A6-4BF8-A92E-04769BB10B85	Not Available;None	Not Available;None	Not Available;None	19;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	775;1140	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0J6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-AO-A0J6-R3101	485e54f5-ff71-42b8-a85c-68c5fe3c3f7e	1	19	273	241	Not Available	9	21	5240	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2008	TCGA-AO-A0J6-01A-11W-A050-09	C2
TCGA-AO-A124	FEMALE	3506	Other, specify	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	3506			TUMOR FREE	NA			38	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A124	b094e8b2-8ece-4b36-8025-18073a8b873c	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	YES	7	-14174	Not Applicable	0	3120	Not Available	Not Available	TCGA-AO-A124-D5932;TCGA-AO-A124-D5934;TCGA-AO-A124-D5933	7bd8d7d3-3c72-4d00-9efb-7b5cc816aae9;02906cd5-712c-423b-8684-6830cf1a7c7e;c107f6da-b6fa-47ff-b3a3-d6edac66e0f4	Not Available;Not Available;Not Available	10;10;10	126;238;126	60;147;60	Doxorubicin;Paclitaxel;Cyclophosphamide	Not Available;Not Available;Not Available	1;1;1	4;5;4	60;175;600	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	424;1600;4240	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A124-F5872;TCGA-AO-A124-F19395	F53CE454-A59B-4F2B-A928-96D5BEEDECDC;4C248C62-B6C3-4222-AA49-AF4679BD9264	Not Available;None	Not Available;None	Not Available;None	7;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	3120;3506	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	mucinous & Ductal	No	C50.9	8523/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A124	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2002	TCGA-AO-A124-01A-11D-A10M-09	C1
TCGA-AO-A128	FEMALE	3248	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	3248			TUMOR FREE	NA			61	Right Lower Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-AO-A128	016caf42-4e19-4444-ab5d-6cf1e76c4afa	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	7	-22340	Not Applicable	0	2877	Not Available	Not Available	TCGA-AO-A128-D5943;TCGA-AO-A128-D5945;TCGA-AO-A128-D5942	e2154fbe-e02b-44f3-a61a-e08146c61db2;39C00F42-C756-42EC-98DC-BB6F6434718B;554dcbf2-b7a5-4237-9b68-7484e41a52ab	Not Available;Not Available;Not Available	10;10;10	124;222;124	82;160;82	Doxorubicin;Paclitaxel;Cyclophosphamide	Not Available;Not Available;Not Available	1;1;1	4;4;4	62;175;619	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	480;1360;4800	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	49	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A128-F5879;TCGA-AO-A128-F19405	2A6DEEAE-C739-4E88-8095-431BF42899E3;CAAF9EFF-2A56-4182-A1F0-115AA2CDDAED	Not Available;None	Not Available;None	Not Available;None	7;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	2877;3248	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	<10%	>=2.0 Positive	0	30	Not Available	52	1.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Negative	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A128	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-AO-A128-R5880	a8fd3954-09d3-4dd2-8fa4-4e734dc2918b	1	7	308	263	Not Available	12	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2002	TCGA-AO-A128-01A-11D-A10M-09	C2
TCGA-AO-A12F	FEMALE	1842	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1842			TUMOR FREE	NA			36	Right Upper Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-AO-A12F	495f9eda-b9be-4eef-bae1-766a4bfbd68e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	8	-13409	Not Applicable	0	1471	Not Available	Not Available	TCGA-AO-A12F-D5981;TCGA-AO-A12F-D5979;TCGA-AO-A12F-D5980	272961f9-9281-4a6c-81c0-f2052b56f0e1;c34652a1-fcbd-42e8-9bfb-991088feb8bd;694d184f-3285-46a6-904c-6c2136c0e92d	Not Available;Not Available;Not Available	10;10;10	189;189;189	63;63;63	Paclitaxel;Cyclophosphamide;Doxorubicin	Not Available;Not Available;Not Available	1;1;1	4;4;4	175;600;60	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A12F-F5899;TCGA-AO-A12F-F19434	D78677C1-3F45-44EB-B8B7-0DCE0D11019D;20F415F8-AAC1-42CF-B61F-F8035EAD23B8	Not Available;None	Not Available;None	Not Available;None	8;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1471;1842	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A12F	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Regional site	TCGA-AO-A12F-R5904	d6634ff1-45f7-48bb-9b16-7b9d2f69a6db	1	8	254	220	Not Available	12	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2006	TCGA-AO-A12F-01A-11D-A10Y-09	C2
TCGA-AO-A1KR	FEMALE	2513	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	2513			TUMOR FREE	NA			51	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AO-A1KR	b7f74ae1-6f58-447c-be50-a7666eb19d9a	Not Available	Negative	4 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	15	-18900	Not Applicable	0	2141	Not Available	NO	TCGA-AO-A1KR-D21772;TCGA-AO-A1KR-D21771;TCGA-AO-A1KR-D21770	3870F7E2-7A57-4F72-B49B-6234D97C5792;BC8E60BC-1325-4D58-8CFC-5647A26B6628;9814E3A1-23C9-4193-94E2-B1E096A02EA1	Not Available;Not Available;Not Available	20;20;20	174;118;118	132;76;76	paclitaxel;cyclophosphamide;doxorubicin	Not Available;Not Available;Not Available	2;2;2	4;4;4	175;600;60	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	3;2;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	658;4512;452	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-AO-A1KR-F21768	72013907-4371-4723-AF90-55C5BC120D64				21		Not Available	Not Applicable	2513		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	1	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A1KR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2011	2005	TCGA-AO-A1KR-01A-12D-A142-09	C1
TCGA-AQ-A04J	FEMALE	819	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	819			TUMOR FREE	NA			45	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AQ-A04J	9938ce5c-e74e-446e-a932-f096f85cc3b1	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	15	-16615	Not Applicable	0	160	Not Available	Not Available	TCGA-AQ-A04J-D10110;TCGA-AQ-A04J-D10098;TCGA-AQ-A04J-D10111	D8796E39-CFDE-459F-9BCD-D002AFF025CF;C6A8B218-BCD7-4F96-B5AB-9B20A7A0B735;9826B415-20EE-4140-A2D8-EA39857695D9	Not Available;Not Available;Not Available	7;7;7	104;104;160	61;61;118	Cytoxan;Adriamycin;Taxol	Not Available;Not Available;Not Available	4;4;4	4;4;4	600;60;175	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	2400;240;700	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AQ-A04J-F10104;TCGA-AQ-A04J-F21740	B746D98E-FBB4-4B00-9F7B-15D7187ED53D;09FC391F-4113-4C17-8BDA-25158626688E	Not Available;None	Not Available;None	Not Available;None	7;20	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	500;819	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	4;2	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2011;2012	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A04J	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	NO	YES	AQ	Breast	Not Applicable	Alive	2010	2009	TCGA-AQ-A04J-01A-02W-A050-09	C2
TCGA-AR-A0TS	FEMALE	2558	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	2558			Not Available	NA			46	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A0TS	972447aa-4332-47e7-bddd-2eb699dbb664	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	8	-17141	Not Applicable	0	1138	Not Available	Not Available	TCGA-AR-A0TS-D19189;TCGA-AR-A0TS-D19194;TCGA-AR-A0TS-D19193	6DDD0B18-B972-42FE-81B7-F4D84C27F23E;3B977891-44ED-474F-973E-0BB631AA37E4;674B9434-AFDB-4831-BF85-31EAEBAB94D1	Not Available;Not Available;Not Available	12;12;12	100;156;100	61;114;61	Doxorubicin;Paclitaxel;Cytoxan	Not Available;Not Available;Not Available	12;12;12	4;4;4	60;175;600	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	460;1320;4600	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A0TS-F18644;TCGA-AR-A0TS-F49516;TCGA-AR-A0TS-F71730	DDE2E871-EE01-4B9E-B31D-D5BB5687213A;4ABA8613-33A6-4918-9B4F-8315C2EDA06A;94425F1E-C3C6-4EF7-B1CD-AA1FBAF14FBE				12;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1138;2275;2558		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	12;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2011;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	2	Not Available	No	A0TS	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A0TS-R18646	B5DA5037-58AA-4B53-B86A-0C254CBEECE0	1	12	228	185	Not Available	12	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006	TCGA-AR-A0TS-01A-11D-A10Y-09	C2
TCGA-AR-A0TU	FEMALE	709	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	709			TUMOR FREE	NA			35	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A0TU	dfe6db17-cf45-488e-bd3c-b8433d7343ca	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	10	-13039	Not Applicable	0	360	Not Available	Not Available	TCGA-AR-A0TU-D19570;TCGA-AR-A0TU-D19572;TCGA-AR-A0TU-D19571	EFEB5E4B-A824-4B78-B373-603E8A1C7BBA;EE4C23A8-EDAC-4DE6-9B48-CD0BCB2D9978;8B38DA0D-2D5D-4484-BC07-F2BF3584123C	Not Available;Not Available;Not Available	15;15;15	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Doxorubicin;Docetaxel;Cytoxan	Not Available;Not Available;Not Available	12;12;12	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A0TU-F18575;TCGA-AR-A0TU-F71735	080FECF7-066F-4CB4-9E67-5ABAE2FBA3EF;3BBB4DAF-8684-4AE4-A54B-691A404D0A5D				15;30		Not Available;None	Not Applicable;Not Applicable	417;709		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A0TU	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006	TCGA-AR-A0TU-01A-31D-A10G-09	C2
TCGA-AR-A1AR	FEMALE	524	Infiltrating Ductal Carcinoma	Breast	Dead	T1	N2	M0	Stage IIIA	1	268	Other, specify	New Primary Tumor	TUMOR FREE	NA			50	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AR-A1AR	eda6d2d5-4199-4f76-a45b-1d0401b4e54c	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Not Available	28	-18482	524	0	Not Available	Not Available	Not Available	TCGA-AR-A1AR-D21852;TCGA-AR-A1AR-D21854;TCGA-AR-A1AR-D21853	A68EA7A7-0E11-4956-8188-70EA2C45DECF;7B4BBD98-19AC-4156-B24A-AE9E584860AB;8E6652BF-209E-4F74-87AE-371F6CB1244D	Not Available;Not Available;Not Available	27;27;27	159;159;159	Not Available;Not Available;Not Available	Docetaxel;Not Available;Doxorubicin	Not Available;Not Available;Not Available	2;2;2	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available		TCGA-AR-A1AR-F21816;TCGA-AR-A1AR-F21825	A22FFD2C-82FF-4832-A3C3-258EE37920E3;9CEE3AB5-7F21-46B0-AB2D-B2102DC1113C				27;27		Not Available;Not Available	524;524	Not Available;Not Available		268;387				Scheduled Follow-up Submission;Additional New Tumor Event							Not Available;Not Available			Not Available;Not Available					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2;2	Other, specify;Other, specify	New Primary Tumor;New Primary Tumor	Breast;Breast	YES;YES																																		WITH TUMOR;WITH TUMOR			Not Available;Not Available			YES;YES		YES;YES	Dead;Dead	2012;2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	5	Not Available	Yes	A1AR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Not Available	TCGA-AR-A1AR-R21851	3B2FC16E-C838-43CC-A732-D6C5969A0532	1	26	251	Not Available	Not Available	2	Not Available	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T1	Not Available	NO	YES	AR	Breast	Not Applicable	Dead	2011	2007	TCGA-AR-A1AR-01A-31D-A135-09	C2
TCGA-AR-A1AY	FEMALE	1026	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	1026			Not Available	NA			65	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AY	5fd9552a-c742-4388-940d-295d1107ae00	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	YES	14	-23927	Not Applicable	0	615	Not Available	Not Available	TCGA-AR-A1AY-D21981;TCGA-AR-A1AY-D21982	4898241A-D0FD-474A-AB71-1B9BC5FBE3F1;4BBF53A3-33EC-452E-ABEB-55BC506B0EBD	Not Available;Not Available	28;28	117;117	Not Available;Not Available	Doxorubicin;Cytoxan	Not Available;Not Available	2;2	4;4	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A1AY-F21977;TCGA-AR-A1AY-F49482	B606F4FD-7228-4416-8B81-02C8861CF309;E5648A84-5439-451B-A1FB-234DA91B8F76				28;2		Not Available;None	Not Applicable;Not Applicable	1026;1026		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	2;10	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1AY	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Not Available	TCGA-AR-A1AY-R21978	D74AC1F9-01CC-47D6-8F12-D8FBADBC40A9	1	28	208	Not Available	Not Available	2	33	6040	NO	Not Available	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Wide Local Excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2008	TCGA-AR-A1AY-01A-21D-A12Q-09	C1
TCGA-AR-A256	FEMALE	2854	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0	M0	Stage IIA	1	1640		Locoregional Disease	Not Available	NA			45	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A256	d3d545b3-457f-4389-821f-704cb24aff7f	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	YES	31	-16642	2854	0	Not Available	Not Available	Not Available	TCGA-AR-A256-D31926;TCGA-AR-A256-D31927	B6C966AC-D18C-4B33-BFE1-11776EA2F338;B4890692-5CC2-43F9-B3F9-89528DD2F720	Not Available;Not Available	22;22	101;101	38;38	Doxorubicin;Cytoxan	Not Available;Not Available	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-AR-A256-F31923	ABDB80D8-BC00-469D-9827-36679803F8EF				11		Not Available	2854	Not Available		1640				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Locoregional Disease	Not Available	YES																																		Not Available			Not Available			YES		NO	Dead	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A256	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Mastectomy	NO	YES	AR	Breast	Not Applicable	Dead	2011	2001	TCGA-AR-A256-01A-11D-A167-09	C2
TCGA-AR-A2LR	FEMALE	1742	Metaplastic Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	1742			TUMOR FREE	NA			49	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A2LR	D093173F-08AB-4138-BF3C-399C45A6E163	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	Not Available	14	-18214	Not Applicable	0	620	Not Available	NO	TCGA-AR-A2LR-D37602;TCGA-AR-A2LR-D37603	03400FAC-D55D-4626-A257-9C1AE7178017;CDD3764F-94E6-493E-8E99-6A9A7370E1B2	Not Available;Not Available	6;6	-1386;-1386	-1428;-1428	Adriamycin;Cytoxan	Not Available;Not Available	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A2LR-F37600;TCGA-AR-A2LR-F71747	22969DEA-7B38-42A9-95BD-4710D4BBFA96;E250D902-9F8D-4000-8C72-4DBD74E19452				6;30			Not Applicable;Not Applicable	846;1742																				NO;NO																						12;3					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						NO;NO		NO;NO	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Metaplastic Carcinoma	Not Applicable	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	Yes	A2LR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A2LR-R37601	892A1FE4-D10E-4BD7-B38E-303B77033602	Not Available	6	-1306	-1347	Not Available	12	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2012	2010	TCGA-AR-A2LR-01A-12D-A18P-09	C2
TCGA-AR-A5QQ	FEMALE	322	Other, specify	Breast	Dead	T3	N1	M0	Stage IIIA	1	301	Other, specify	Locoregional Recurrence	TUMOR FREE	NA			68	Right	Axillary lymph node dissection alone	Not Available	TCGA-AR-A5QQ	3AF31FCF-AD0C-4FD9-A8E3-10F9176B5E9D	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	15	-24841	322	0	Not Available	Not Available	Not Available	TCGA-AR-A5QQ-D43954;TCGA-AR-A5QQ-D43955;TCGA-AR-A5QQ-D43958;TCGA-AR-A5QQ-D43960;TCGA-AR-A5QQ-D43962;TCGA-AR-A5QQ-D43964	1E5134F3-A59A-400F-B7B0-64A9497A1897;BE51B815-9DB6-447D-8819-873D08EDAB68;A25A87ED-0EBE-4D81-AE56-A8F243B5743B;7E77E139-F8F0-4B5C-8487-8CAAF7C8D746;DD9E6CBF-F1BB-4B39-AEBA-AA7A777C9EEC;64A6D9AB-D9A7-47AE-BB5D-FC484F6E56ED	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10;10	91;91;143;143;143;143	69;69;119;119;119;119	Carboplatin;Taxol;Ifosfamide;MESNA-1;MESNA-2;VP-16	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6;6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Ancillary;Ancillary;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2013;2013;2013;2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A5QQ-F42734	8318BD8E-9128-4A44-AB63-98E5A2459230				10			322	Not Available																				NO																						6					Not Available	Not Available	Not Available	301	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Lung	Distant Metastasis	Liver, bone, chest wall, adrenal glands	Not Available	Not Available	YES	WITH TUMOR						YES		YES	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Squamous (metaplastic) carcinoma	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	24	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	301;301;301;301;301	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Other, specify;Lung;Liver;Bone;Other, specify	Locoregional Recurrence;Distant Metastasis;Distant Metastasis;Distant Metastasis;Distant Metastasis	chestwall;Not Available;Not Available;Not Available;Adrenal glands	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	YES	1	Not Available	No	A5QQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	YES	Primary Tumor Field	TCGA-AR-A5QQ-R42765	36D43FF0-8472-4D18-9916-39F7D4FAF10C	Not Available	10	233	Not Available	Not Available	6	34	6120	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T3	Not Available	NO	YES	AR	Breast	Not Applicable	Dead	2013	2011	TCGA-AR-A5QQ-01A-11D-A28B-09	C1
TCGA-BH-A0B3	FEMALE	1203	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1203			TUMOR FREE	NA			53	Right Upper Inner Quadrant;Right Upper Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0B3	18eb4dfc-556f-4bf3-a411-4780209ed1e0	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Other	Not Applicable	NO	3	-19479	Not Applicable	0	1203	Not Available	Not Available	TCGA-BH-A0B3-D15420;TCGA-BH-A0B3-D15419;TCGA-BH-A0B3-D15421	13E5B5DC-2CA1-474B-A21D-B7AD5884839B;49AB6F59-1B1E-4B04-914E-82339768A10C;E89062E2-7543-4BBA-9DA0-D4F6C81279C6	Not Available;Not Available;Not Available	3;3;3	115;115;213	52;52;136	CYCLOPHOSPHAMIDE;Doxorubicin;Paclitaxel	Not Available;Not Available;Not Available	11;11;11	4;4;12	1128;113;154	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	4540;454;1873	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0B3-F15418	493B0584-FAA6-475F-97F9-CFE0524DF460				3		Not Available	Not Applicable	1203		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	29	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	No	A0B3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0B3-R15422	F9F1D8C1-B2FA-4516-B98F-D50ACCB6C8C6	1	3	72	24	Not Available	11	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2007	TCGA-BH-A0B3-01A-11W-A071-09	C1
TCGA-BH-A0B9	FEMALE	1572	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	1572			TUMOR FREE	NA			44	Right Lower Inner Quadrant;Right Lower Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-BH-A0B9	5a57dc25-d252-4b22-b192-4de630d7002f	Not Available	Negative	Not Available	0	Not Available	Not Evaluated	Negative	Other	Not Applicable	NO	4	-16310	Not Applicable	0	1572	Not Available	Not Available	TCGA-BH-A0B9-D15440;TCGA-BH-A0B9-D15439	13B25C27-6D31-4812-9A44-FC50A5A1DFA8;D648DF65-E9A7-46B4-8758-F6D2241D7892	Not Available;Not Available	4;4	111;111	48;48	CYCLOPHOSPHAMIDE;Doxorubicin	Not Available;Not Available	11;11	4;4	950;95	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3800;380	mg;mg	Not Available;Not Available	2010;2010	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0B9-F15438	2C430BC9-3919-471B-B6F0-EE5346626686				4		Not Available	Not Applicable	1572		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2010	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0B9	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0B9-R15441	BB3B3DEB-1D17-48BB-B0BF-5491D69AAC51	1	4	180	132	Not Available	11	34	6240	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2006	TCGA-BH-A0B9-01A-11W-A071-09	C1
TCGA-BH-A0BG	FEMALE	1871	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	1871			TUMOR FREE	NA			73	Left Lower Outer Quadrant	Not Available	Not Available	TCGA-BH-A0BG	4f608829-ffc4-4527-886e-6bc764ab29f5	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	8	-26988	Not Applicable	0	756	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0BG-F58615	C970540D-F1A7-425C-BEF1-2AD70CD6AD13				16			Not Applicable	1871																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0BG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0BG-R58616	FBA2D677-DEA7-483C-AA88-82D4D14CB644	Not Available	16	131	84	Complete Response	4	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Segmental mastectomy with sentinel axillary lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2008	TCGA-BH-A0BG-01A-11D-A10Y-09	C2
TCGA-BH-A0BL	FEMALE	2278	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	2278			TUMOR FREE	NA			35	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A0BL	92b5de82-0221-4df1-8094-80f40c0bb4fa	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	8	-12841	Not Applicable	0	1340	Not Available	NO	TCGA-BH-A0BL-D59190;TCGA-BH-A0BL-D59191;TCGA-BH-A0BL-D59192	3DFD3BA5-2A34-4B70-AC12-5D1FAFE94711;9D3B5CF6-D53E-4A6E-9E36-96AEF566A22F;A18467A5-0B9F-4D1C-97E4-44F1D31AE8F3	Not Available;Not Available;Not Available	2;2;2	142;142;240	72;72;163	Adriamycin;Cytoxan;Taxol	Complete Response;Complete Response;Complete Response	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0BL-F59189	3F9A600B-3723-4F22-9943-AFDBE30523C5				2			Not Applicable	2278																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0BL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Segmental mastectomy with sentinel lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007	TCGA-BH-A0BL-01A-11D-A10Y-09	C2
TCGA-BH-A0E0	FEMALE	134	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N3a	M0	Stage IIIC	0	134			TUMOR FREE	NA			38	Left Upper Outer Quadrant;Left Lower Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-BH-A0E0	20e8106b-1290-4735-abe4-7621e08e3dc8	Not Available	Negative	Not Available	0	Not Available	Not Evaluated	Negative	Modified Radical Mastectomy	Not Applicable	NO	9	-14175	Not Applicable	0	134	Not Available	Not Available	TCGA-BH-A0E0-D4599;TCGA-BH-A0E0-D4596;TCGA-BH-A0E0-D4593	8EB7D1DE-E03C-401A-A845-0B5329E85271;DF2372AA-F01A-4FB6-9656-6FE9E01FE4E1;B2E22558-CF61-46B8-90DA-D2B204CF8D7A	Not Available;Not Available;Not Available	18;18;18	143;143;143	38;38;38	DOCETAXEL;DOXORUBICIN;CYCLOPHOSPHAMIDE	Not Available;Not Available;Not Available	11;11;11	6;6;6	130;87;820	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	763;503;5034	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	H-SCORE 0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0E0-F4603	8EA495C0-4ADC-49A9-9235-6D360CB615E2	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	134	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	No	A0E0	TUMOR FREE	H-SCORE 0	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0E0-R4601	7729AB44-C0F8-40F3-A012-E97C7F94CAC7	1	22	255	198	Not Available	11	Not Available	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N3a	T3	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009	TCGA-BH-A0E0-01A-11W-A071-09	C1
TCGA-BH-A0RX	FEMALE	170	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	170			TUMOR FREE	NA			59	Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-BH-A0RX	e828455d-4680-41b2-8a1c-1582e3790d62	Not Available	Negative	Not Available	0	Not Available	Not Evaluated	Negative	Other	Not Applicable	NO	11	-21857	Not Applicable	0	170	Not Available	Not Available	TCGA-BH-A0RX-D4873;TCGA-BH-A0RX-D4872;TCGA-BH-A0RX-D4874	5D132A06-F3D4-4E01-ACBA-37EBA9BACD22;CBEF5FFD-0B68-4780-939F-C001E4A34CCB;A90F4DFB-A730-4F63-B6A4-BDC3570C9474	Not Available;Not Available;Not Available	18;18;18	155;155;155	50;50;50	Fluorouracil;Cyclophosphamide;Methotrexate	Not Available;Not Available;Not Available	11;11;11	6;6;6	1122;1122;75	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	6808;6808;447	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	H-Score 0	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	Not Available	TCGA-BH-A0RX-F4875	4CFEECD1-12BC-496C-9B8E-2E006F072A1E	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	170	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0RX	TUMOR FREE	H-Score 0	Not Available	Not Available	H-Score	H-Score	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2010	TCGA-BH-A0RX-01A-21D-A099-09	C2
TCGA-BH-A0WA	FEMALE	701	Not Available	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	701			TUMOR FREE	NA			82	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-BH-A0WA	786e8dbe-442e-4551-87b3-b4c333b04dd4	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	16	-30025	Not Applicable	0	372	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0WA-F34068	B26AA90B-6D51-4807-902F-8E6B2E695140				29		Not Available	Not Applicable	701		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	3	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	No	A0WA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2008	TCGA-BH-A0WA-01A-11D-A10G-09	C1
TCGA-BH-A18G	FEMALE	149	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	149			Not Available	NA			81	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A18G	747083ff-0703-431b-aad4-f2adff739516	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	1	-29820	Not Applicable	0	61	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A18G-F64216	112BA8BF-77D2-4E83-AAFE-9FABF7EC76CA				27			Not Applicable	149																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.5	8500/3	C50.5	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A18G	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A18G-R64217	911630F0-5BE2-4E57-8DB4-987BF400F086	Not Available	27	149	103	Complete Response	8	25	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	right segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2010	TCGA-BH-A18G-01A-11D-A12B-09	C1
TCGA-BH-A18V	FEMALE	1556	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	0	1556			Not Available	NA			48	Right	Axillary lymph node dissection alone	Not Available	TCGA-BH-A18V	6b960b58-28e1-41c6-bd6e-7e669c6aa4ef	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	2	-17682	1556	0	Not Available	Not Available	YES																								Not Available	Not Available	NOT HISPANIC OR LATINO	Other, specify	axilaary node negative but intrammary node positive	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.4	8500/3	C50.4	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	25	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A18V	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Modified radical mastectomy with left breast biopsy	NO	YES	BH	Breast	Not Applicable	Dead	2011	2001	TCGA-BH-A18V-01A-11D-A12B-09	C2
TCGA-BH-A1EW	FEMALE	1694	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIA	0	1694			WITH TUMOR	NA			38	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A1EW	9d166970-07c8-4ca3-9cfa-ed0049df9ecc	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	7	-14090	1694	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	16	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	Not Available	No	A1EW	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Left segmental mastectomy with level 1 and level 2 axillary dissection	NO	YES	BH	Breast	Not Applicable	Dead	2011	1999	TCGA-BH-A1EW-01A-11D-A135-09	C2
TCGA-BH-A1F6	FEMALE	2965	Infiltrating Ductal Carcinoma	Breast	Dead	T4d	N2a	MX		0	2965			Not Available	NA			51	Left	Not Available	Not Available	TCGA-BH-A1F6	ad18820b-a804-49c0-ba8a-86c09fa6bce2	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	7	-18691	2965	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	6	Not Available	No	A1F6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	MX	N2a	T4d	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1996	TCGA-BH-A1F6-01A-11D-A13L-09	C2
TCGA-BH-A1FC	FEMALE	3472	Medullary Carcinoma	Breast	Dead	T1c	N1b	M0	Stage IIA	0	3472			TUMOR FREE	NA			78	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A1FC	b97bf89a-7a85-4eef-ae7e-f787aead1f0a	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	8	-28706	3472	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Medullary Carcinoma	Not Applicable	No	C50.9	8510/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Available	23	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	Not Available	No	A1FC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T1c	localized segmental mastectomy with axillary node dissection	NO	YES	BH	Breast	Not Applicable	Dead	2011	1998	TCGA-BH-A1FC-01A-11D-A13L-09	C2
TCGA-BH-A42U	FEMALE	3364	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	3364			Unknown	NA			80	Right	Not Available	Not Available	TCGA-BH-A42U	2DC1CEC9-925A-417F-9E21-3C2143E711B4	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	Not Available	1	-29330	Not Applicable	0	3324	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A42U-F61923	19515634-4B7A-46FC-8FFD-C9C2EB15C93A				10			Not Applicable	3364																				NO																						7					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A42U	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	BH	Breast	Not Applicable	Alive	2012	2004	TCGA-BH-A42U-01A-12D-A243-09	C2
TCGA-C8-A12V	FEMALE	385	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	385			TUMOR FREE	NA			55	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A12V	7e1673f8-5758-4963-8804-d5e39f06205b	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	22	-20346	Not Applicable	0	0	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A12V-F19095	12E9D7F7-A7A6-4E0F-B152-CE708D83BA6C				2		Not Available	Not Applicable	385		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Negative	Not Evaluated	5	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A12V	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010	TCGA-C8-A12V-01A-11D-A10Y-09	C2
TCGA-C8-A131	FEMALE	411	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	411			TUMOR FREE	NA			82	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A131	c49e3b18-fd88-48f4-8b01-300692ceb367	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	15	-29966	Not Applicable	0	14	Not Available	NO	TCGA-C8-A131-D70828;TCGA-C8-A131-D70829;TCGA-C8-A131-D70830	D5B3D28A-4333-4455-9FCB-220B0A14A5FB;FF1D85A6-7EFA-489D-B455-FF6D8C7D3E33;F291DB2B-45ED-4BD2-98A3-63F012802AC3	Not Available;Not Available;Not Available	9;9;9	57;57;57	34;34;34	5-Flourouracil;Doxorubicin;Cyclophosphamide	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-C8-A131-F19083;TCGA-C8-A131-F70827	1EFBD51F-B7D9-44A2-9EB5-A651DD80FDC4;FD18DE54-343A-43E7-9EA3-010208D98744				2;9		Not Available;None	Not Applicable;Not Applicable	68;411		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2010;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	4	Not Available	No	A131	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010	TCGA-C8-A131-01A-11D-A10Y-09	C1
TCGA-C8-A1HJ	FEMALE	5	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	5			TUMOR FREE	NA			53	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A1HJ	a855c228-a263-44df-87a0-cbc32187e3f5	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	1	-19629	Not Applicable	0	5	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	10	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	Not Available	Not Available	No	A1HJ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010	TCGA-C8-A1HJ-01A-11D-A13L-09	C2
TCGA-C8-A26X	FEMALE	376	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N1	M0	Stage IIA	0	376			TUMOR FREE	NA			58	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-C8-A26X	70ab4f23-23c4-409f-a5cc-18a010c3a24e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	21	-21463	Not Applicable	0	11	Not Available	Not Available	TCGA-C8-A26X-D70793;TCGA-C8-A26X-D70794;TCGA-C8-A26X-D70795	C99DA711-C86E-4BA8-8AD6-9274208C28D7;CFD4307C-F098-4A9C-A34B-E337C15B7BDC;69033C6A-572E-4B72-BB72-027C7F663381	Not Available;Not Available;Not Available	9;9;9	207;207;207	200;200;200	5-Flourouracil;Cyclophosphamide;Doxorubicin	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A26X-F70792	521990DD-93CE-4A11-ABED-112046F3A659				9			Not Applicable	376																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A26X	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T1	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010	TCGA-C8-A26X-01A-31D-A16D-09	C1
TCGA-C8-A26Y	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	0			TUMOR FREE	NA			90	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-C8-A26Y	4d51159f-ab2f-40e3-a363-847c3654431e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	21	-32872	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A26Y-F70791	D698E40F-5055-4DF2-962D-C3BE9150CBE3				9			Not Applicable	0																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A26Y	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010	TCGA-C8-A26Y-01A-11D-A16D-09	C1
TCGA-C8-A27B	FEMALE	439	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	439			TUMOR FREE	NA			48	Left	Not Available	Not Available	TCGA-C8-A27B	f0d8a1fe-e313-44f1-99cc-b965cbeeff0e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	21	-17763	Not Applicable	0	30	Not Available	Not Available	TCGA-C8-A27B-D70782;TCGA-C8-A27B-D70783;TCGA-C8-A27B-D70784;TCGA-C8-A27B-D70785	DA6B28FB-BAD1-4A40-9E5F-0B1F39CF0496;C4415E67-02A8-44F6-A28B-1ADA98E0EFC9;AB7C57F0-657B-482F-BAD3-11C849B1AD7D;18D1F0D1-A458-40F2-B27C-6E5C94FED213	Not Available;Not Available;Not Available;Not Available	9;9;9;9	85;85;85;85	62;62;62;62	5-Flourouracil;Cyclophosphamide;Doxorubicin;Taxol	Complete Response;Complete Response;Complete Response;Complete Response	3;3;3;3	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2015;2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A27B-F70781	034E528F-AA4B-4323-B33B-521853E5E8E5				9			Not Applicable	439																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	Not Available	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A27B	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2011	TCGA-C8-A27B-01A-11D-A167-09	C2
TCGA-C8-A3M7	FEMALE	1034	Infiltrating Lobular Carcinoma	Breast	Dead	T4b	N0	M0	Stage IIIB	1	1034		Locoregional Recurrence	TUMOR FREE	NA			60	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-C8-A3M7	959FF069-8A49-4C9B-85C2-5291CAC0ACFF	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	6	-22096	Not Applicable	0	1	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A3M7-F70838	BFE6A7FF-9238-485C-836E-9BE96855EF6D				9			1034	Not Available																				NO																						3					NO	NO	Not Available	1034	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Locoregional Recurrence	Not Available	NO	Not Available	YES	WITH TUMOR						YES		YES	Dead	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A3M7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T4b	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2012	2010	TCGA-C8-A3M7-01A-12D-A21Q-09	C2
TCGA-D8-A13Z	FEMALE	635	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0		0	635			Not Available	NA			51	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A13Z	5a17dcd9-5ced-4a69-8069-23c7fd0649d1	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	27	-18942	Not Applicable	0	210	Not Available	Not Available	TCGA-D8-A13Z-D20732;TCGA-D8-A13Z-D65313;TCGA-D8-A13Z-D65314	CB4478D0-5504-4268-A2E9-9EFE2B5C293F;7EBDCBDC-E474-41D4-8D9F-2B99158B6829;D08EFDD4-5EBB-4816-910D-C6EAC35DE992	Not Available;Not Available;Not Available	14;22;22	157;157;157	52;52;52	doxorubicine;cyclophosphamide;tamoxifen	Not Available;Not Available;Not Available	1;9;9	6;Not Available;Not Available	6x97.8;Not Available;Not Available	mg/m2;Not Available;Not Available	ADJUVANT;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	586.8;Not Available;Not Available	mg;Not Available;Not Available	Not Available;NO;NO	2012;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A13Z-F20731	444554B2-937F-4327-A7CC-E6A2B5BDC2B7				14		Not Available	Not Applicable	635		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	9	Not Available	No	A13Z	Not Available	Not Available	Hercep Test  TM Dako	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-D8-A13Z-R20733	022E96E7-CD23-4434-A287-97397DC0002B	Not Available	14	210	184	Not Available	1	18	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010	TCGA-D8-A13Z-01A-11D-A10Y-09	C1
TCGA-D8-A143	FEMALE	431	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	431			TUMOR FREE	NA			51	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A143	1c40b84e-a0e3-429f-a48c-21566cf881c0	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	25	-18984	Not Applicable	0	172	Not Available	Not Available	TCGA-D8-A143-D13818;TCGA-D8-A143-D64910	786A632D-1981-4D67-B28C-DFEA95E74CCA;655A6770-6A40-4D7C-9453-094F18309168	Not Available;Not Available	4;15	172;172	67;67	doxorubicin;cyclophosphamide	Not Available;Not Available	7;9	6;Not Available	60;Not Available	mg/m2;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	AC;Not Available	IV;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	mg/m2;Not Available	Not Available;NO	2011;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A143-F13817	A3F360DB-0BEF-4CC5-8175-D859A234AF9E				4		Not Available	Not Applicable	431		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	No	A143	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010	TCGA-D8-A143-01A-11D-A10Y-09	C1
TCGA-D8-A147	FEMALE	584	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0		0	584			Not Available	NA			45	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A147	fc18d029-9be2-4fa0-9aef-6d647dc55f0b	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Not Available	27	-16736	Not Applicable	0	2	Not Available	Not Available	TCGA-D8-A147-D20738;TCGA-D8-A147-D64911;TCGA-D8-A147-D64912;TCGA-D8-A147-D64913	A5E59A9B-F5F1-45A0-B6D1-DB44F0A7168B;CEB8DA00-D300-4AFB-BE1C-2BD15BF0E020;C92110BF-B562-4AFE-A419-2217BD718E8F;063BD28B-E3D7-44D7-BEA3-38407B9852F0	Not Available;Not Available;Not Available;Not Available	14;15;15;15	135;135;135;135	21;21;21;21	doxorubicine;cyclophosphamide;paclitaxel;docetaxel	Not Available;Not Available;Not Available;Not Available	1;9;9;9	5;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	mg;Not Available;Not Available;Not Available	Not Available;NO;NO;NO	2012;2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A147-F20737	6B778912-AC2E-4C50-A3F5-4D28049BE764				14		Not Available	Not Applicable	584		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Hercep Test  TM Dako	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	1	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	No	A147	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A147-R20739	C093FF02-9F16-4B3D-89AA-4760FC8CA1DC	Not Available	14	223	188	Not Available	1	1 brachy+25	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010	TCGA-D8-A147-01A-11D-A10Y-09	C2
TCGA-D8-A1JF	FEMALE	366	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N2a	M0	Stage IIIA	0	366			TUMOR FREE	NA			79	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JF	dcd5e079-813a-4c1a-b320-0931468d2bbc	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	28	-29199	Not Applicable	0	96	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JF-F14058	B68084F0-7E58-4822-841C-EEF1C187A504				18		Not Available	Not Applicable	366		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Negative	Not Evaluated	25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	No	A1JF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010	TCGA-D8-A1JF-01A-11D-A13L-09	C2
TCGA-D8-A1JL	FEMALE	611	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	611			TUMOR FREE	NA			72	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JL	aa4244a8-0454-4247-a1c3-357fd51746fa	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	29	-26484	Not Applicable	0	265	Not Available	Not Available																								manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JL-F20747	DCA53598-A604-4C2E-BC24-67A6AD8B8D49				15		Not Available	Not Applicable	611		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	DAKOHercepTest TM	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A1JL	TUMOR FREE	manual counting	Not Available	Not Available	0%	0%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010	TCGA-D8-A1JL-01A-11D-A13L-09	C2
TCGA-D8-A1XK	FEMALE	441	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	441			TUMOR FREE	NA			55	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XK	97943d87-fed7-4f14-a0a7-c5bfee64c392	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	9	-20092	Not Applicable	0	326	Not Available	NO	TCGA-D8-A1XK-D30075;TCGA-D8-A1XK-D30076	A849F857-16FA-41BF-8358-A98B7681F21B;25913AF2-0E2D-4199-A59A-8CB451696BDF	Not Available;Not Available	4;2	233;128	149;65	paclitaxelum;doxorubicine+cyclophosphamide	Not Available;Not Available	2;4	12;4	80;97.2+972	mg/m2/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1560;388.8+3888	mg;mg	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XK-F30074	6E9797E4-9661-4BDD-9F1E-1EC2D1DB381B				4		Not Available	Not Applicable	441		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	3	Not Available	No	A1XK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1XK-R30073	4AF40BF7-8C93-4618-8EA8-7F5FAAC782D9	Not Available	2	281	253	Not Available	4	45	9000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010	TCGA-D8-A1XK-01A-21D-A14K-09	C2
TCGA-D8-A1XQ	FEMALE	499	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	499			TUMOR FREE	NA			69	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XQ	3886b4fb-ba22-4a50-b11a-a6893951f170	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	16	-25345	Not Applicable	0	177	Not Available	NO																								% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XQ-F29449	E3365AFC-09F9-4524-A456-5208C249283D				26		Not Available	Not Applicable	499		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1XQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	0%	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010	TCGA-D8-A1XQ-01A-11D-A14K-09	C2
TCGA-D8-A27F	FEMALE	488	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	488			TUMOR FREE	NA			40	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A27F	1549dc64-3dab-43fc-96e9-b07d520957e1	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	18	-14731	Not Applicable	0	106	Not Available	NO	TCGA-D8-A27F-D29516	623BDB83-F7A0-4C0E-8D45-D2C8A45913FF	Not Available	21	488	379	adriamycin+cyclophosphamide	Not Available	3	6	60+600	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	360+3600	mg	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27F-F29515	57370D31-378D-4228-9DAA-39A366A418B6				21		Not Available	Not Applicable	488		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Negative	Not Evaluated	11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	0	No	A27F	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A27F-R29517	971EDB07-58FF-45DD-9E58-5B6F0310BF2A	Not Available	21	182	158	Not Available	3	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010	TCGA-D8-A27F-01A-11D-A16D-09	C1
TCGA-D8-A27M	FEMALE	410	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	410			TUMOR FREE	NA			59	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A27M	ae65baeb-6b78-492a-8c63-bb7e93e83dc2	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	17	-21910	Not Applicable	0	145	Not Available	NO	TCGA-D8-A27M-D29593	0BE1EFFF-4959-45B6-A90D-D5954D024746	Not Available	26	238	84	methotrexate+5 fluorouracil+cyclophosphamide	Not Available	3	6	40+600+100	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	240+3600+600	mg	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27M-F29592	F7028889-8575-484F-8C51-2F75DA0740BC				26		Not Available	Not Applicable	410		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A27M	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011	TCGA-D8-A27M-01A-11D-A16D-09	C2
TCGA-E2-A14N	FEMALE	1434	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1434			TUMOR FREE	NA			37	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A14N	752ad011-79e0-494f-9868-98bf6feb28f8	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	31	-13743	Not Applicable	0	1350	Not Available	NO	TCGA-E2-A14N-D19160;TCGA-E2-A14N-D19181;TCGA-E2-A14N-D19180	774B35C1-A2FE-4E38-9361-04E5C80ED934;17CBAB16-10F1-4630-8C6E-81E28038C433;9E98636D-8BD0-483C-B86A-593FAEF2D5B4	Not Available;Not Available;Not Available	17;17;17	148;148;64	64;87;64	Cyclophosphamide;Docetaxel;Doxorubicin	Not Available;Not Available;Not Available	11;11;11	5;4;1	1100;135;110	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	5444;540;110	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A14N-F19154	374DA424-B865-46D4-A433-F702C840CF36				17		Not Available	Not Applicable	1434		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	38	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	Not Available	No	A14N	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A14N-R19182	7722E80A-C0A5-4B7D-95C4-6BBF762D55DD	1	17	236	181	Not Available	11	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2007	TCGA-E2-A14N-01A-31D-A135-09	C2
TCGA-E2-A14R	FEMALE	1174	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	1	971	Other, specify	New Primary Tumor	TUMOR FREE	NA			62	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A14R	4fba3deb-db94-44b5-a0f2-a575d270779e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	6	-22686	Not Applicable	0	845	Not Available	NO	TCGA-E2-A14R-D18840;TCGA-E2-A14R-D18842;TCGA-E2-A14R-D18841;TCGA-E2-A14R-D18839	02D7B362-61D3-42D6-85CD-44CEAFE39454;4742335F-157B-4689-A300-FE62F824234D;71BC8838-707A-4B8B-A57B-65DF043E1B53;1F3203CD-3D0A-40D3-95B5-5B07E4987795	Not Available;Not Available;Not Available;Not Available	24;24;24;24	131;187;145;131	89;128;145;89	Doxorubicin;Paclitaxel (Protein-Bound);Paclitaxel;Cyclophosphamide	Not Available;Not Available;Not Available;Not Available	10;10;10;10	4;3;1;4	143;610;413;1428	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;2;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	572;1832;413;5712	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	NO	YES	YES		TCGA-E2-A14R-F18838	818079A8-A928-4AC6-9779-E8A587D960DB				24		971	Not Applicable	1174		971				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	10	Other, specify	New Primary Tumor	Endometrial	YES																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A14R	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-E2-A14R-R18843;TCGA-E2-A14R-R18845	71319FB6-5CE9-4A19-8D5C-34C64A295435;0DD87532-955B-43DE-A40E-7952D8993908	1;2	24;24	259;1061	210;1026	Not Available;Not Available	10;10	33;25	6040;4500	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	ADJUVANT;ADJUVANT	Not Available;Not Available	cGy;cGy	2011;2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008	TCGA-E2-A14R-01A-11D-A10Y-09	C1
TCGA-E2-A14X	FEMALE	972	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	972			TUMOR FREE	NA			55	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A14X	60df7543-6da5-4c75-943b-5800c1e08234	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	6	-20105	Not Applicable	0	692	Not Available	NO	TCGA-E2-A14X-D18865;TCGA-E2-A14X-D18863;TCGA-E2-A14X-D18864;TCGA-E2-A14X-D18861;TCGA-E2-A14X-D18866	FE204945-F99F-464A-9E6F-D168A421C139;FCF5541F-112D-4384-BD87-6B4BCBAD598D;A9E35661-F258-4F47-B234-1EEDC19E838C;A713574D-B6F2-4C3E-A90D-81F33EAB041C;DB24F34E-51A3-4AF7-A17C-27D81176D60D	Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4	97;188;199;280;97	55;55;111;182;55	doxorubicin;avastin;paclitaxel;clodronic acid;cyclophosphamide	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	2;7;5;Not Available;2	128;1470;171;75200;1284	mg;mg;mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;2;1	IV;IV;IV;PO;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy	Not Available;Not Available;Not Available;clinical trial - bisphosphonates as adjuvant therapy;Not Available	512;9310;1642;75200;5136	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A14X-F18857	02DF16E7-CE1F-4746-952C-B32F958EF48B				4		Not Available	Not Applicable	972		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	5	Not Available	No	A14X	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-E2-A14X-R18859	F63A992C-A3FF-4949-86BE-6556F627B1A3	1	4	271	218	Not Available	11	36	6640	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009	TCGA-E2-A14X-01A-11D-A10Y-09	C2
TCGA-E2-A150	FEMALE	1935	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1935			TUMOR FREE	NA			48	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A150	4ac693e9-10f3-46b3-9d46-df3af7b0d259	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	6	-17580	Not Applicable	0	591	Not Available	NO	TCGA-E2-A150-D18517;TCGA-E2-A150-D18518;TCGA-E2-A150-D18516	DBDE6E37-20B6-4FD1-9ADE-F324268AEF35;34429660-1923-46C7-9C89-A412C2A9DE79;6E72775A-C321-47EC-B622-DD6248D502F6	Not Available;Not Available;Not Available	7;7;7	96;129;66	24;80;24	Doxorubicin;Paclitaxel (Protein-Bound);Cyclophosphamide	Not Available;Not Available;Not Available	11;11;11	4;4;4	122;398;1218	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	488;1719;4872	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A150-F18515;TCGA-E2-A150-F71066	38FBBD18-BAE7-4FA6-89D9-DD317944D96B;F53AF7A3-7480-40A2-99D1-87493C41A28F				7;18		Not Available;None	Not Applicable;Not Applicable	773;1935		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	10;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A150	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A150-R18519	D82259A3-46D2-4F2F-A3B4-42F0AF6342D8	1	7	202	154	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009	TCGA-E2-A150-01A-11D-A12B-09	C2
TCGA-E2-A158	FEMALE	450	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1mi	M0	Stage IIA	0	450			TUMOR FREE	NA			43	Left Upper Inner Quadrant;Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A158	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	7	-15903	Not Applicable	0	450	Not Available	NO	TCGA-E2-A158-D18963;TCGA-E2-A158-D18958;TCGA-E2-A158-D18960;TCGA-E2-A158-D18961	B94489C2-71D2-40FE-86DD-A3E999BF3373;A3051694-896A-4A9D-9178-CA248163F114;8C16F7B2-EFBC-4B7E-AA40-8A152D0E4F0F;67C4C12D-8CB3-4ED8-8913-666D05A6057D	Not Available;Not Available;Not Available;Not Available	8;8;8;8	Not Available;228;228;228	450;Not Available;Not Available;Not Available	arimidex;doxorubicin;cytoxan;Taxane	Not Available;Not Available;Not Available;Not Available	11;11;11;11	Not Available;Not Available;Not Available;Not Available	1;Not Available;Not Available;Not Available	mg;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;1;1;2	PO;Not Available;Not Available;Not Available	YES;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	mg;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A158-F18956	24E85CD5-EEC3-42FE-A66B-6A8DEE474B14				8		Not Available	Not Applicable	450		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	Yes	A158	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009	TCGA-E2-A158-01A-11D-A12B-09	C1
TCGA-E2-A1L7	FEMALE	1836	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	1	1619	Other, specify	New Primary Tumor	TUMOR FREE	NA			40	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E2-A1L7	791c5768-f0f5-4ab6-86eb-998e5c4b49e3	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	1	-14854	Not Applicable	0	633	Not Available	NO	TCGA-E2-A1L7-D20590;TCGA-E2-A1L7-D20589;TCGA-E2-A1L7-D20592;TCGA-E2-A1L7-D20594;TCGA-E2-A1L7-D20591	36955FD4-89C2-4248-AAA1-8D8CE8F1DA04;B07261AA-1C81-4C97-9D43-2C0E1543ABFF;0C4583A4-E88D-4BDE-9CB3-9938094B71F8;EAECF0E4-3985-48CF-AB0D-2AC40D9B4036;42D99A31-F6C7-4E6D-9F04-7D6E1901B392	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	83;83;Not Available;Not Available;153	41;41;170;240;97	Cyclophosphamide;Doxorubicin;Clodronate;Arimidex;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1	4;4;Not Available;Not Available;4	1200;120;1600;1;359	mg;mg;mg/day;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;3;4;2	IV;IV;PO;PO;IV	NO;NO;YES;YES;NO	Chemotherapy;Chemotherapy;Other, specify in notes;Hormone Therapy;Chemotherapy	Not Available;Not Available;Phase III Clinical Trial;Not Available;Not Available	4800;480;1600;1;1436	mg;mg;mg/day;mg/day;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	Allred score 1+1 = 2	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A1L7-F20588;TCGA-E2-A1L7-F70298	3F50F013-BAFD-4D4C-915F-4D9CF0494F7A;0E0A1363-5109-4CB5-B655-FCBCEF191361				12;16		Not Available;None	Not Applicable;Not Applicable	834;1836		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;NO	None;YES	None;1662	None;1619	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Negative	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Negative	None;Other, specify	None;New Primary Tumor	None;left breast	None;YES	None;Not Available	None;YES	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	7	Not Available	No	A1L7	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 2	Not Available	YES	Not Available	WHITE	Not Available	Regional site;Primary Tumor Field	TCGA-E2-A1L7-R20596;TCGA-E2-A1L7-R70387	DB702F0D-3D33-490B-8DBE-AB55654B03A8;D9FCDCF6-AA31-494F-918B-042E492EEDF2	1;Not Available	12;16	237;1735	191;1694	Not Available;Complete Response	1;3	33;30	6040;60	NO;NO	EXTERNAL BEAM;External	Not Applicable;Not Applicable	ADJUVANT;Not Available	Not Available;Not Available	cGy;Gy	2012;2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009	TCGA-E2-A1L7-01A-11D-A142-09	C2
TCGA-E2-A1LH	FEMALE	3247	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	3247			TUMOR FREE	NA			59	Right	Sentinel node biopsy alone	Not Available	TCGA-E2-A1LH	d8ecba6a-9fff-4993-a799-9a8d2aea524e	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	NO	3	-21628	Not Applicable	0	2876	Not Available	NO	TCGA-E2-A1LH-D20652;TCGA-E2-A1LH-D20659	908E780C-09EB-4CBC-AD5A-75B352A71460;2D696153-39F9-4F7D-8E35-5B056E1F654F	Not Available;Not Available	12;12	104;104	41;41	Adriamycin;Cytoxan	Not Available;Not Available	1;1	4;4	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1LH-F20649	29497476-76A6-4D7C-9478-FBA0801FDFDF				12		Not Available	Not Applicable	3247		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1LH	TUMOR FREE	Not Available	ACIS	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A1LH-R20662	08EE86D2-364F-4AA5-9959-6D8413398AD2	1	12	189	147	Not Available	1	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2002	TCGA-E2-A1LH-01A-11D-A14G-09	C2
TCGA-E2-A1LL	FEMALE	1309	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N2a	MX	Stage IIIA	1	1303	Liver	Distant Metastasis	TUMOR FREE	NA			73	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E2-A1LL	2a84997d-ccee-4f46-bea2-752534f26416	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	3	-27028	Not Applicable	0	1014	Not Available	NO	TCGA-E2-A1LL-D20617;TCGA-E2-A1LL-D20618	9EECED51-430D-48E6-9828-E3E8CF095C2A;8FE9F6AA-8F33-41C4-8D94-56C3DA00BD0B	Not Available;Not Available	17;17	49;49	49;49	Docetaxel;Cyclophosphamide	Not Available;Not Available	1;1	1;1	158;1260	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	158;1260	mg;mg	Not Available;Not Available	2012;2012	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	NO	NO	NO		TCGA-E2-A1LL-F20616	A4E4C69D-7D3F-41E4-AF0A-681E4603326E				17		Not Available	Not Applicable	1309		1303				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Liver	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	44	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	5	Not Available	No	A1LL	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Regional site	TCGA-E2-A1LL-R20619	544DB6E4-9E02-45A2-ACCB-0254D6BB05D9	1	17	147	105	Not Available	1	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N2a	T3	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008	TCGA-E2-A1LL-01A-11D-A142-09	C1
TCGA-E2-A1LS	FEMALE	1604	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	1604			TUMOR FREE	NA			46	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A1LS	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	3	-16887	Not Applicable	0	239	Not Available	NO	TCGA-E2-A1LS-D20604;TCGA-E2-A1LS-D20606	225992D9-0568-4DD6-BF26-D1C6E065C3DE;ECEACF6D-18C4-4309-8AA5-54E2B721DAFE	Not Available;Not Available	17;17	112;112	Not Available;Not Available	Cyclophosphamide;Taxotere	Not Available;Not Available	1;1	4;4	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Allred score 0+0 = 0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A1LS-F20603;TCGA-E2-A1LS-F70016	512AFC08-F4A9-4570-91A2-F8F491877292;D73A246D-93CE-4E3C-8364-A243EFA91C86				17;9		Not Available;None	Not Applicable;Not Applicable	470;1604		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1LS	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010	TCGA-E2-A1LS-01A-12D-A159-09	C2
TCGA-E9-A5FL	FEMALE	24	Metaplastic Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	24			TUMOR FREE	NA			65	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A5FL	E3935CE4-64D3-4A66-BA11-D308B844B410	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	22	-24053	Not Applicable	0	8	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E9-A5FL-F56061	20890005-DE58-433A-9DDF-39C1F4A0FDDF				24			Not Applicable	24																				YES																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Metaplastic Carcinoma	Not Applicable	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A5FL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2013	2012	TCGA-E9-A5FL-01A-11D-A27P-09	C1
TCGA-EW-A1OV	FEMALE	789	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1mi	MX	Stage IIB	0	789			TUMOR FREE	NA			56	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A1OV	ac68d219-5670-4ddd-8df6-8aa7ad59e5c7	Negative	Negative	3 Point Scale	Not Available	3 Point Scale	Modified radical mastectomy	Negative	Lumpectomy	Not Applicable	YES	27	-20764	Not Applicable	0	523	Not Available	NO	TCGA-EW-A1OV-D30309;TCGA-EW-A1OV-D30310;TCGA-EW-A1OV-D30308;TCGA-EW-A1OV-D29120	A35B4531-1DC9-46D1-A861-9056798B1594;D43BD34B-E399-4B01-9711-CFC5C3099BB2;438AC993-E582-4312-9218-95B3B4AF3C80;0F1217D3-7BF4-4145-9240-DE1C87BE3F50	Not Available;Not Available;Not Available;Not Available	7;7;7;8	252;314;252;252	203;273;203;203	Epirubicin;Docetaxel;Cyclophosphamide;Fluorouracil	Not Available;Not Available;Not Available;Not Available	3;3;3;3	3;3;3;3	178;180;890;890	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	538;545;2690;2690	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	<10%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1OV-F29119	803F6927-592D-459C-AC6D-DBEB52CA6344				8		Not Available	Not Applicable	789		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	1.8	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	6	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	1	No	A1OV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1mi	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2009	TCGA-EW-A1OV-01A-11D-A142-09	C2
TCGA-EW-A1P4	FEMALE	907	Medullary Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	907			TUMOR FREE	NA			43	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A1P4	521e2140-ae5b-456f-8699-97398d009687	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	11	-15989	Not Applicable	0	501	Not Available	NO	TCGA-EW-A1P4-D29687;TCGA-EW-A1P4-D29689	79E0A6AE-A364-45A1-9ED5-E0FBDD00DAA9;E8073733-F67A-40F9-88DA-22013C8ED597	Not Available;Not Available	26;26	144;144	73;73	Docetaxel;Cyclophosphamide	Not Available;Not Available	3;3	4;4	75;600	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	TC;TC	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	<10%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1P4-F29684	45EAB7C6-BFBF-48EC-B18C-19642B61C70E				26		Not Available	Not Applicable	907		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Medullary Carcinoma	Not Applicable	No	C50.9	8510/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1P4	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A1P4-R29685	1B09106F-D19A-436A-AE7E-6DE51BA1A9B4	1	26	263	208	Not Available	3	Not Available	15,900	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2009	TCGA-EW-A1P4-01A-21D-A142-09	C2
TCGA-EW-A1P8	FEMALE	239	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N3b	M0	Stage IIIC	1	207	Lung	Distant Metastasis	WITH TUMOR	NA			58	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A1P8	359f12f9-5c41-48a4-85bc-fd7e307bf7d8	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	NO	27	-21501	239	0	Not Available	Not Available	YES	TCGA-EW-A1P8-D29122;TCGA-EW-A1P8-D29632;TCGA-EW-A1P8-D29633	995CBFB8-E6D5-4374-A924-F0E06B3CCB01;24AB482A-B1B6-4E84-B3EA-F5F8952F6019;BE0E1D18-E1B5-4E37-AD2C-75B257D2F899	Not Available;Not Available;Not Available	8;22;22	140;140;140	40;40;40	Fluorouracil;Epirubicin;Cyclophosphamide	Not Available;Not Available;Not Available	3;3;3	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	FEC x3;FEC x3;FEC x3	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	<10%	NOT HISPANIC OR LATINO	Lung;Bone;Liver;Other, specify	skin	Not Available	Not Available	Not Available	NO		TCGA-EW-A1P8-F29121	8F96B637-28EF-44CB-901F-20EA615880C7				8		Not Available	239	Not Available		207				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Lung	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			YES		NO	Dead	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	<10%	Negative	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	Negative	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	Negative	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	3 Point Scale	Not Available	3 Point Scale	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	14	Not Available	No	A1P8	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3b	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Dead	2011	2010	TCGA-EW-A1P8-01A-11D-A142-09	C2
TCGA-EW-A1PB	FEMALE	608	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a	MX	Stage IIIA	0	608			TUMOR FREE	NA			70	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-EW-A1PB	88db1340-e4bf-451a-87c0-6e9168296f5e	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	18	-25770	Not Applicable	0	608	Not Available	Not Available																								Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1PB-F29107	3AAF57DA-E30C-45A6-B7DD-53CC5EA84417				8		Not Available	Not Applicable	608		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	2	Not Available	No	A1PB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1a	T3	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2009	TCGA-EW-A1PB-01A-11D-A142-09	C2
TCGA-EW-A1PH	FEMALE	607	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	607			TUMOR FREE	NA			52	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A1PH	4da999a0-ef41-4a0b-b1d1-446b39cc855a	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	YES	27	-19073	Not Applicable	0	140	Not Available	NO	TCGA-EW-A1PH-D30304;TCGA-EW-A1PH-D30306;TCGA-EW-A1PH-D29111;TCGA-EW-A1PH-D30305;TCGA-EW-A1PH-D29113	2DDB37C1-2B90-4032-8C74-3AB053366DB0;8C772D08-80AB-49A9-9CAC-40EEADDB8D31;E98E3894-4A1F-4559-AA6C-977995AAADD4;3C59E6BD-8791-41EF-A738-A127DA2E0088;CE3771B3-13A0-460B-B9C7-C17BAA64C06A	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	140;161;140;140;271	98;161;98;98;215	Cyclophosphamide;Docetaxel;Fluorouracil;Epirubicin;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	3;1;3;3;8	835;169;835;167;124	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;2	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	2505;169;2505;501;992	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	Not Available	<10%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-EW-A1PH-F29110;TCGA-EW-A1PH-F41145	7268DC2D-2021-4105-BF63-E0D421464BDB;1D45F7E0-49FF-4FE9-AB11-639270B50BAF				8;12		Not Available;None	Not Applicable;Not Applicable	425;607		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	0	No	A1PH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A1PH-R32259	B13D295F-A310-4C1A-9812-BFC67F771E56	1	20	322	276	Not Available	4	34	6120	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2010	TCGA-EW-A1PH-01A-11D-A14K-09	C2
TCGA-EW-A6SB	FEMALE	760	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage II	0	760			TUMOR FREE	NA			62	Left;Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A6SB	5C59028F-B8FA-4811-8314-BE3EAED5F364	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	YES	12	-22844	Not Applicable	0	760	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	8	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A6SB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	Not Available	Not Available	EW	Breast	Not Applicable	Alive	2015	2012	TCGA-EW-A6SB-01A-12D-A32I-09	C2
TCGA-GM-A2DB	FEMALE	2406	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	2406			TUMOR FREE	NA			62	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-GM-A2DB	6E6B7742-A562-490B-BB72-04A5653852E4	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	28	-22883	Not Applicable	0	1616	Not Available	NO	TCGA-GM-A2DB-D47159;TCGA-GM-A2DB-D47161;TCGA-GM-A2DB-D47162;TCGA-GM-A2DB-D47163	FCDFC8F4-07C3-4F53-A0E4-135FC08A31D6;8109884C-3338-42A4-8167-9ABEF5678D23;9C452D7D-4120-4BFE-B788-AEF890F1DA60;9DB393BE-D1F8-4423-BE3A-1201B189B8E6	Not Available;Not Available;Not Available;Not Available	22;22;22;22	167;248;248;248	91;181;181;181	Taxol;Fluorouracil;Epirubicin;Cytoxan	Complete Response;Complete Response;Complete Response;Complete Response	8;8;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.50					TCGA-GM-A2DB-F47156	5F9BC2B1-50F3-4A6F-9B76-6BE7330FCA84				22			Not Applicable	2406																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	60	Not Available	1.67	1.11	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A2DB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-GM-A2DB-R47157	D6AC4D25-3614-447E-8DF4-09A1DBE09817	Not Available	22	317	271	Complete Response	8	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2006	TCGA-GM-A2DB-01A-31D-A19Y-09	C1
TCGA-GM-A2DF	FEMALE	2155	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	2155			TUMOR FREE	NA			53	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-GM-A2DF	D6F7AFC0-1558-43AD-ACB1-2B5311ED2264	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	29	-19614	Not Applicable	0	1299	Not Available	NO	TCGA-GM-A2DF-D47077;TCGA-GM-A2DF-D47078;TCGA-GM-A2DF-D47079;TCGA-GM-A2DF-D47080	9309E85C-511C-4D64-A9FD-153D7D059F76;BD3CED99-2972-42AC-A40F-65D713B00CF1;9759BFEA-6BA0-47F3-8697-D4BE5FD98515;0DE09D9B-CDA0-4E1C-A438-47238333BAF8	Not Available;Not Available;Not Available;Not Available	22;22;22;22	159;229;229;229	82;166;166;166	Taxol;Fluorouracil;Epirubicin;Cytoxan	Complete Response;Complete Response;Complete Response;Complete Response	8;8;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.40					TCGA-GM-A2DF-F47074	5EA23820-4945-4615-B3D5-2407C809951B				22			Not Applicable	2155																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	60	Not Available	1.57	1.12	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	32	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	0	No	A2DF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-GM-A2DF-R47076	097C40A5-1D8D-4E81-8D6E-2BCBC0783E3E	Not Available	22	294	250	Complete Response	8	32	64	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2007	TCGA-GM-A2DF-01A-11D-A17W-09	C2
TCGA-GM-A2DH	FEMALE	2193	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i+)	M0	Stage I	0	2193			TUMOR FREE	NA			58	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-GM-A2DH	5700C1B3-922A-4401-8AB8-89028908D696	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	29	-21344	Not Applicable	0	1286	Not Available	NO	TCGA-GM-A2DH-D47082;TCGA-GM-A2DH-D47083;TCGA-GM-A2DH-D47084;TCGA-GM-A2DH-D47085	556C375B-CFAB-497E-AE7A-22BC00FC3826;BA77ECF0-0A86-4F8A-9268-57921470CEC6;5D627B00-9BA1-4D32-971B-CCE6AF02327A;4B6748E0-604F-422B-9752-189DFFF16BD8	Not Available;Not Available;Not Available;Not Available	22;22;22;22	163;233;233;233	86;170;170;170	Taxol;Fluorouracil;Adriamycin;Cytoxan	Complete Response;Complete Response;Complete Response;Complete Response	8;8;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.80					TCGA-GM-A2DH-F47081	42FCC169-41BB-48F3-BB58-86689559BD62				22			Not Applicable	2193																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	60	Not Available	2.80	1.00	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	1	No	A2DH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T1c	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2007	TCGA-GM-A2DH-01A-11D-A17W-09	C2
TCGA-HN-A2NL	FEMALE	79	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	79			TUMOR FREE	NA			56	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-HN-A2NL	124B693C-77DC-4FA8-B703-54E8B5054A92	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	30	-20483	Not Applicable	0	79	Not Available	Not Available	TCGA-HN-A2NL-D60150;TCGA-HN-A2NL-D60151	FC632444-8B7E-4F7E-94DD-B12171B1E0D6;D9161F5E-D3C5-4B6F-8267-C280BAEBD2D4	Not Available;Not Available	30;30	Not Available;Not Available	59;59	Cyclophosphamide;Doxorubicin	Unknown;Unknown	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2014;2014	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available					TCGA-HN-A2NL-F60149	0CBA7FE6-A784-4125-BBE8-43108D8E03E2				30			Not Applicable	79																				YES																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		Unknown	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	0	0	No	A2NL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	Not Evaluated	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	HN	Breast	Not Applicable	Alive	2014	Not Available	TCGA-HN-A2NL-01A-11D-A18P-09	C2
TCGA-LL-A5YO	FEMALE	440	Infiltrating Ductal Carcinoma	Breast	Alive	T1b	N0	MX	Stage IA	0	440			TUMOR FREE	NA			50	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-LL-A5YO	B8AEFC48-4A6E-4254-A57F-5F688399B582	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	8	-18354	Not Applicable	0	97	Not Available	Not Available	TCGA-LL-A5YO-D43017;TCGA-LL-A5YO-D43018	2796DB97-696B-4A10-94A8-0596D8A2F43E;9E63512F-49BD-4691-8C4D-920BA81A33D7	Not Available;Not Available	8;8	160;160	56;56	TAXOTERE;CYTOXAN	Complete Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;YES	2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LL-A5YO-F58638	8D9AF5E1-0A39-49CE-9F74-CB0D3A1E192E				17			Not Applicable	440																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A5YO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-LL-A5YO-R58642	4B671EF3-EA8C-45F5-9CCC-C2189FB3DF30	Not Available	17	210	192	Complete Response	4	15	40/48	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T1b	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2013	2013	TCGA-LL-A5YO-01A-21D-A28B-09	C2
TCGA-LL-A73Y	FEMALE	477	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	MX	Stage IA	0	477			TUMOR FREE	NA			67	Right;Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-LL-A73Y	EA645243-DF49-4466-A255-9F3D4321E357	Not Available	Negative	3 Point Scale	3+	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	12	-24647	Not Applicable	0	126	Not Available	Not Available	TCGA-LL-A73Y-D51201;TCGA-LL-A73Y-D51202	F696F179-D694-412F-9044-A859E9371783;E1AF783B-A8A8-4502-92CE-C221FF5DE1BD	Not Available;Not Available	12;12	126;126	42;42	taxotere;cytoxan	Unknown;Unknown	11;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LL-A73Y-F67099	E9959843-2F90-4BF2-B36D-9C4F8836A0E1				30			Not Applicable	477																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A73Y	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T1c	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2013	2013	TCGA-LL-A73Y-01A-11D-A33E-09	C2
TCGA-OL-A6VO	FEMALE	858	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	MX	Stage IA	0	858			TUMOR FREE	NA			43	Right;Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-OL-A6VO	398FB71B-CA83-44E7-BF0D-B1CA464B0283	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Not Available	5	-15780	Not Applicable	0	480	Not Available	Not Available	TCGA-OL-A6VO-D63192;TCGA-OL-A6VO-D65548	CE66AA70-6EA4-4FAA-84F8-24A41673E3CE;AB34EC19-3799-4671-962A-F4C7E3E37EA6	Not Available;Not Available	12;25	147;147	71;71	TAXOTERE;Cytoxan	Complete Response;Complete Response	8;10	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A6VO-F59365	E7A38310-96E2-4B1D-93D6-BF1D8DC187E4				10			Not Applicable	858																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.23	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	7	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A6VO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-OL-A6VO-R63547	C53F9699-EC12-450E-A717-917D11632C0A	Not Available	12	201	156	Complete Response	8	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T1c	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2012	TCGA-OL-A6VO-01A-12D-A33E-09	C1
TCGA-S3-AA10	FEMALE	586	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	586			TUMOR FREE	NA			65	Right;Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-S3-AA10	23C31C2E-336C-4878-A476-CF8D811B4875	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	18	-24075	Not Applicable	0	241	Not Available	Not Available	TCGA-S3-AA10-D58351;TCGA-S3-AA10-D58352;TCGA-S3-AA10-D58354;TCGA-S3-AA10-D67781	765A1845-816A-48C0-B600-D8D63C2E7DE9;A162E470-A31A-43EF-B7CC-48C25D10E121;DFEAFB3D-F85C-4E98-96CE-3BB8DAE7C12E;DA1D7D41-7834-410C-959E-8D9D35DD679C	Not Available;Not Available;Not Available;Not Available	18;18;18;11	199;199;199;Not Available	75;75;75;265	CYTOXAN;TAXOTERE;NEULASTA;ANASTROZOLE	Complete Response;Complete Response;Complete Response;Not Applicable	4;4;4;11	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Ancillary;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	CAP scoring guideline 2010	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-S3-AA10-F67528;TCGA-S3-AA10-F70351;TCGA-S3-AA10-F70441	B1B67534-2F82-46FC-896D-E6CFB68E03A2;4F48B8A5-A0CB-4E1C-8ADA-12F1C6814B66;D3E73401-5961-4C83-8C9D-2E93151A962C				11;26;26			Not Applicable;Not Applicable;Not Applicable	468;523;586																				NO;NO;NO																						11;2;2					Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE						YES;YES;YES		NO;NO;NO	Alive;Alive;Alive	2014;2015;2015	FEMALE	Not Available	CAP scoring guideline 2010	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	AA10	TUMOR FREE	CAP scoring guideline 2010	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	S3	Breast	Not Applicable	Alive	2014	2013	TCGA-S3-AA10-01A-21D-A41F-09	C2
TCGA-S3-AA15	FEMALE	525	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a		Stage IIB	0	525			TUMOR FREE	NA			51	Right;Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-S3-AA15	E783E518-C1E5-4EAC-8EAF-E2D65CCD9692	Not Available	Negative	Not Available	Not Available	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	18	-18659	Not Applicable	0	209	Not Available	Not Available	TCGA-S3-AA15-D58380;TCGA-S3-AA15-D58381;TCGA-S3-AA15-D58382;TCGA-S3-AA15-D58383	0B7D016E-CC28-4274-BF66-92AC08BD4CCD;CD0DBE0D-1FF4-4A8C-A3EF-5397C30A382A;4ACE7463-6DB8-42D6-93B0-327859CD747E;B4C53B22-0A11-4216-A8A3-EE51B419C715	Not Available;Not Available;Not Available;Not Available	18;18;18;18	125;125;125;236	82;82;82;138	ADRIAMYCIN;CYTOXAN;NEULASTA;TAXOL	Complete Response;Complete Response;Complete Response;Complete Response	4;4;4;4	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Ancillary;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	CAP SCORING GUIDELINE 2010	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-S3-AA15-F67625;TCGA-S3-AA15-F70445;TCGA-S3-AA15-F72098	516DF8F3-0887-44F0-B851-A01356DE4536;0C3A9677-3AAE-427C-836E-B83B55F9497A;90913D52-D037-495E-ADB9-41512D877984				7;26;10			Not Applicable;Not Applicable;Not Applicable	421;509;525																				NO;NO;NO																						11;2;4					Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE						YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2014;2015;2015	FEMALE	Not Available	CAP SCORING GUIDELINE 2010	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	0	No	AA15	TUMOR FREE	CAP SCORING GUIDELINE 2010	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-S3-AA15-R67624	FE3E452E-46DC-46B1-9014-9F6A43D28C78	Not Available	7	359	286	Complete Response	11	57	114	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	cM0 (i+)	N1a	T2	Not Available	YES	NO	S3	Breast	Not Applicable	Alive	2014	2013	TCGA-S3-AA15-01A-11D-A41F-09	C2
